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Abstract
This thesis work focuses on designing thin polyelectrolyte multilayer (PEM) films via layer-by-
layer (LbL) deposition technique with the ability to kill pathogenic bacteria and inactivate human
viruses, especially the influenza (flu) virus on contact. This work builds on four years of
research at the Institute for Soldier Nanotechnologies (ISN) focusing on creating new, non-
leaching microbicidal material; this film is envisioned to be used as permanent surface coatings
for weapons, equipments, uniforms, personal items, etc. because a small reduction in the rate of
infection will greatly enhance the readiness and performance of soldiers and other military
personnel. Extending this application to everyday life, commonly handled objects such as
doorknobs, computer keyboards, and touch screens can also be made sterile by coating them with
these highly effective microbicidal PEM films. These films can also be used to prevent
infections and long-term bacterial biofilms on implant surfaces. The ultimate aim of this thesis
work is to create a broadly applicable multifunctional platform film technology that will satisfy
various thin film surface coating applications; this film will impart a surface with long term
antimicrobial / antifouling functionality via a permanent microbicidal base, and controlled
delivery of a therapeutic agent via a hydrolytically degradable top film as needed. Efforts were
focused on maximizing and understanding the factors that influence the microbicidal /
antifouling property of the film; thus far, we successfully designed a set of contact-killing
ionically cross-linked polymeric thin films; a hydrophobic polycation, linear NN-
dodecyl,methyl- poly(ethylenimine) (DMLPEI) with microbicidal activity was layered with a
hydrophilic polyanion, such as poly(acrylic acid) (PAA), to create LbL films highly effective
against Escherichia coli and Staphylococcus aureus (Gram negative and positive bacteria,
respectively), as well as the influenza A/WSN (H1N1) virus. The microbicidal film was also
demonstrated to significantly resist adsorption of protein from blood plasma relative to an
uncoated substrate. By generating PEM films assembled with the hydrophobic N-alkylated
poly(ethylenimine) and the hydrophilic poly(acrylic acid), an ultrathin film that exhibited
antifouling and antimicrobial properties was created. Results showed that a fine balance of
hydrophobicity and hydrophilicity on the surface of the films was needed to create molecular-
level heterogeneities unfavorable to protein adsorption; due to the contrasting nature of the
polymer making up the film, nanoscale segregation of the polymer segments into hydrophobic
and hydrophilic moieties could occur on the surface. We then moved on to design a dual
functional LbL film construct combining the permanent microbicidal / antifouling base film with
a hydrolytically degradable PEM top film offering controlled and localized delivery of
therapeutics (e.g. antibiotic, anti-inflammatory drug, etc.). When the degradable top film is
completely eroded, the surface will be left with the permanent microbicidal film for long-term
prevention of fouling by biomolecules and microorganisms (e.g., proteins and bacteria).
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Chapter 1: Background and Significance
1.1 Introduction
One of the main focuses of this thesis work is to create polyelectrolyte multilayer (PEM)
films via the Layer-by-Layer (LbL) deposition technique with the ability to kill pathogenic
bacteria and inactivate human viruses, especially the various pathogenic strains of influenza
viruses. PEM films are attractive because of their simple and economical fabrication process,
and they can be built on most surfaces of various shapes and sizes with nanometer scale control
over morphology and surface properties. ' PEM films are also known to be robust and adhere to
surfaces well; hence, PEM films have tremendous potential to be used as coatings on various
surfaces and objects to impart them with microbicidal functionality. On top of that, PEM films
have also been investigated extensively for use in biomedical applications, 5 membranes and
electrodes for energy applications, 6-8 and various stimuli-responsive surfaces. 911
The thesis work presented here builds on four years of Institute for Soldier
Nanotechnologies (ISN) research focused on creating new, non-leaching bactericidal, virucidal,
and fungicidal surfaces, which will dramatically reduce the spread of influenza and possibly
other pathogenic microbe infections in the battlefield. These microbicidal films can be used to
coat surfaces on weapons, equipments, uniforms, personal items, filters and so on because a
small reduction in the chances of influenza infections will greatly enhance the readiness and
performance of soldiers and other military personnel. Extending this application to everyday
life, imagine if commonly handled objects like doorknobs, computer keyboards, and toys can be
made microbicidal (bactericidal and virucidal) by coating them with these PEM films. Bacteria
such as Escherichia coli (E.coli) and Staphylococcus aureus (S.aureus) are the most common
cause of infections in people, and the rise of antibiotic resistant strains of these bacteria (e.g.,
methicillin-resistant S.aureus (MRSA)) has become a serious problem. On the other hand,
annually approximately 5% to 20% of the United States population acquires the influenza (flu)
virus. Out of this percentage, more than 200,000 people are hospitalized, and about 36,000
people die. 12 The flu virus is one of the most common and dangerous human pathogens; it
becomes a very serious problem when a new, most likely an avian strain of the flu virus becomes
infective to humans. These viruses spread easily from person to person through droplets formed
while coughing and sneezing. In addition, touching respiratory droplets on surfaces of objects
can also transmit the flu virus; " therefore, if common surfaces can be made microbicidal,
bacterial infections and the spread of influenza can be reduced drastically.
Apart from the above mentioned applications, PEM films have also been investigated
extensively to deliver therapeutic agents such as antibiotics 2,14, proteins 15, anti-inflammatory
agents 3,16, and growth factors ' 17, 1 for medical applications. These films can also be built using
degradable polymers, creating the opportunity to design multifunctional combination films
consisting of permanent and degradable multilayers within a single film construct. One of the
most attractive properties of these PEM films is that the therapeutic agents can be incorporated
into them at the exact layer of interest, resulting in high drug loading per volume of the film.
Also, since most of the time the LbL technique is carried out in an all-aqueous fabrication
condition, incorporation of biologically active materials such as anti-inflammatory agents,
proteins, and DNA are possible without denaturing them.
In recent years, there has been great interest in designing drug - device combinations for
medical applications, including cardiovascular prostheses, orthopedic implants, stents, etc. 2, 19-22
with the idea of reducing adverse foreign body response (FBR) and other implant-related
complications (e.g., bacterial infections and fouling by biomolecules and microorganisms) via
localized delivery of therapeutics. When a foreign material is implanted in a person's body,
protein from blood adsorbs onto the surface within seconds (biofouling by protein), " which then
triggers an inflammation cascade as part of the wound healing response to protect the body from
foreign objects; in some cases, this may lead to encapsulation of the implanted material. 24,2
Localized delivery of anti-inflammatory agents could help in mediating a FBR, or if surfaces of
medical implants/devices can be functionalized with a film construct that prevents fouling by
protein in the first place, complications arising from FBR can be drastically reduced.
Implant-related infections can occur on any implanted objects ranging from minimally
invasive contact lenses and temporary urinary catheters, to permanent cardiac valves and
orthopedic implants. 20 More importantly, systemic bacteria circulating the bloodstream can
become pathogenic upon attachment to a foreign material surface at any time after implantation;
upon attachment, the bacteria colonize the surface ultimately leading to the formation of a
biofilm, which is a matrix of sessile bacteria consisting of approximately 15% bacterial cells and
85% hydrophobic exopolysaccharide fibers.24 Biofilms can damage surrounding tissues and give
rise to planktonic bacterial cells capable of spreading infections.26 This again necessitates the
design of drug - device combination that provide long-term prevention of bacteria colonization,
and at the same time capable of eliminating pre-existing infection at the implant site.
As mentioned before, biofouling by protein on the surface of medical implants triggers a
FBR; in general, biofouling can be described as undesired accumulation of biomolecules and
organisms (proteins, bacteria, algae, etc.) on wetted surfaces. This is a major problem not only
in medical applications, but also in the food packaging industry, membranes filtration devices,
marine equipments, and so on. 27-29 Biofouling usually results in reduction of sensitivity and
efficacy of the devices. Protein adsorption on surfaces has also been shown to create an
environment suitable for bacterial colonization, and eventually forming a biofilm. 2
In this thesis work, I present a set of multifunctional nondegradable contact killing
microbicidal and antifouling PEM films, incorporating a family of polymeric hydrophobic
quaternary polycations with potent microbicidal activity into LbL films. We then move on to
design a single film construct combining the microbicidal / antifouling film with a hydrolytically
degradable top film incorporating therapeutic agents for biomedical implants applications.
1.2 Layer-by-Layer (LbL) Deposition of Polyelectrolyte Multilayer (PEM) Films
LbL deposition is a very attractive assembly technique for PEM films. This assembly
method was first described in the early 1990s by Decher et al. 30 In this technique, multivalent
species (molecules, polymers, nanoparticles, etc.) with complementary functional groups are
adsorbed sequentially onto a functionalized substrate; the films can be built up via electrostatic
or other non-covalent interactions, including hydrogen bonding. 31,32 For example, a positively
charged polyelectrolyte (polycation) is adsorbed onto a negatively charged substrate, followed by
the adsorption of a negative polyelectrolyte (polyanion). 30,3 This LbL deposition techniques can
also be started with a positively charged substrate. The PEM film is built up by repeating the
bilayer assembly process shown in Figure 1-1. A bilayer architecture is denoted:
(polycation/polyanion)., where n is the number of bilayers adsorbed on the substrate. This is
carried out by dipping the negatively charged substrate in bath containing a positively charged
species, followed by rinsing of the non-specifically bound species. This assembly technique is
possible because with each step, slight charge overcompensation prevents more like-charged
polyelectrolyte from adsorbing but allows the next oppositely charged polymer to be adsorbed. 3,
3 3 This charge overcompensation is possible due to charge screening and is favored because of
entropy gain from the release of counter ion when the polyelectrolyte is incorporated into the
interface. It has also been shown that the polyelectrolyte layers formed are not well stratified,
instead they interdigitate. 36
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Figure 1-1: Schematic of layer-by-layer assembly. Beaker 1 = polyanion, beaker 2 & 4 = water rinse
bath, beaker 3 = polycation. 33
Some of the factors that control the growth behavior of a PEM film are pH, ionic strength
(salt concentration), molecular weight of polymer, solvent used, humidity, temperature, drying
between steps, deposition time, and polymer concentration. Schoeler et al. show that film
thickness is a strong function of pH, 3 and that for a weak polyelectrolyte system of poly(acrylic
acid) and poly (allylamine hydrochloride) (PAA/PAH), the thickness of a single layer of
polymer can be adjusted from 0.5 nm to 8 nm by changing the charge density of the weak
polyelectrolyte. "
The film thickness is highly dependent upon the salt concentration of the polymer
solution as well. Dubas and Schlenoff observed that the film thickness of a 10 bilayer
poly(styrene sulfonate) (PSS) / poly(diallyldimethylammonium chloride) (PDADMAC) system
increased linearly over a NaCl concentration range of 10' M to 2 M. 3 At low salt
concentration, the polymer can displace the salt ions more effectively and bind more tightly to
the substrate. At high salt concentration, the polymer will adhere to the substrate more loosely,
thus forming a loopier molecular layer. At high enough salt concentration, it is possible for the
polymer to completely desorb from the surface. 44 Also, using salt ions with higher valency is
functionally similar to having higher salt concentration of a lower charge salt ion.
The effect of molecular weight of polymer on the morphology of PEM films is species
dependent because of difference in charge densities, steric hindrance, etc. along the polymer
backbone. Four different PEM systems were studied by Houska et al. and it was concluded that
the thickness of the first deposited layer did not depend on the molecular weight of the polymer.
However, the overall thickness of the PEM film does increase with increasing molecular weight.
4' Lower molecular weight polymers have shorter chains thus cannot make as many ion pairs
with the substrate surface as compared to higher molecular weight polymer which has longer
chains. The insufficiency in ion pairs sometimes allow the shorter chain polymer to detach
during subsequent deposition step due to interaction with larger polyelectrolyte of opposite
charge. 42 The three-zone model for PEM film: 43 precursor zone (I), core zone (II), and outer
zone (III) was verified by Porcel et al. where it was shown that the core zone eventually reaches
a constant size at which point the film growth transitions into the linear regime. They also found
that the molecular weight of the polymer does not significantly affect the linear growth regime of
a hyaluron (HA) / poly(L-lysine) (PLL) and poly(glutamic acid) (PGA) / PAH systems. Both of
these systems have been shown to grow exponentially in the initial stages, but transition to linear
growth after more than 15 bilayers. " PEM film has been shown to exhibit two type of film
growth behavior: linear and exponential.
Drying between deposition steps has also been studied, and has been shown to increase
film thickness because of increased surface roughness. " Other studies have also shown that
drying in between deposition steps can result in thinner film on the contrary; 46 hence, the effect
of drying in between steps is system dependent.
As mentioned before, LbL deposition is very effective in building nanometer thick film
with control over its morphology and surface properties. It is also a gentle aqueous assembly
technique where small biomolecules like proteins, polysaccharides, DNA, etc. can be
incorporated. ' Additionally, this process is not limited to only a particular substrate. The film
properties have been found to be independent of the substrate used, so the PEM film can be
constructed on surfaces of any shape, size, and material. Furthermore, LbL deposition is not
limited to only electrostatic assembly; hydrogen bonding, biological interactions, and even
covalent crosslinking have been successfully utilized for construction of PEM films. 33,47 Other
than dipping as shown in Figure 1-1, LbL deposition can also be done with misting 48,49 and spin
coating; 'o both assembly methods have been shown to be very effective in depositing conformal
coating onto substrates. With the highly versatile properties of PEM films, LbL technology has
been applied to countless applications, including drug delivery, membranes and electrodes for
energy applications, biosensors, electrochromic devices, etc. 2,3,6,8,47,51,52
1.2.1 Layer-by Layer Applications in Bactericidal PEM film
PEM films made using the LbL technique have been developed to be bactericidal. Thus
far, no literature has reported the use of PEM film to inactivate viruses; hence, the application for
PEM film presented in this thesis work is novel and exciting. Some of the more common
polymers and metals incorporated into PEM films for bactericidal activity include silver ions, "5
54 silver nanoparticles, 55,56 titania (TiO2) 56 chitosan, 57,58 dextran (anti-adhesive), " etc.
Li et al. created a two-level bactericidal coating with polyelectrolyte and nanoparticle
multilayer deposition; the film kills bacteria by releasing embedded silver ions (chemical-
releasing killing) and via immobilized quaternary ammonium salt (contact killing). The film was
constructed via LbL deposition using PAH and PAA as the polyelectrolytes. Then, a cap region
made of PAH and Si0 2 nanoparticles is added on top of the bilayers. The cap region is then
modified with a quaternary ammonium silene, OQAS. Silver ions are loaded inside the
PAH/PAA bilayers. The system exhibits very high bactericidal activity in the beginning from
the release of the silver ions, and significant antibacterial activity (~ 90%) after the depletion of
the silver ions. " The disadvantage of this type of PEM film is it is releasing a biocide into the
environment, and this is not always desirable.
Antibacterial coating using hydrogen-bonded multilayers containing silver nanoparticles
have also been investigated. Efficacy of the film against Gram positive (S.epidermidis) and
Gram negative (E.coli) bacteria was tested using the Kirby-Bauer disk diffusion test; the zone of
inhibition (Zol) increases as the number of bilayers deposited increase. It is also reported that
incremental increase in the ZoI requires exponential increase in the amount of silver ions
released. " Bactericidal coating made of poly (L-lysine)/hyaluronic acid (PLL/HA) multilayer
films and micrometer-sized liposome aggregates loaded with silver ions were created by Malcher
et al. The encapsulated silver nitrate was released by increasing temperature over the transition
temperature of the vesicles (34*C). A 4-log reduction in the number of viable E.coli bacterial
cells was observed. " One of the disadvantages of this approach is that the embedded silver
agents will eventually be exhausted, leading to limited functional lifetime. More importantly,
silver salts have been shown to be cytotoxic to tissues at high local concentration. *
Some PEM films were designed to limit bacterial adhesion and viability by modifying the
chemical and physical properties of the material surface. Lichter et al. built PEM thin films
comprised of poly (allylamine) hydrochloride (PAH) and poly (acrylic acid) (PAA) over a range
of conditions to explore the physicochemical and mechanical characteristics of material surfaces
controlling adhesion of Staphylococcus epidermidis bacteria and subsequent colony growth.
They found that adhesion of viable S. epidermidis was directly correlated to the stiffness of the
polymeric substrate; however, it was independent of the roughness, interaction energy, and
charge density of the material. Similar trends were observed for wild type and actin analogue
mutant E.coli suggesting that these results were not confined to only specific bacterial cells. 61
These results bring about an additional parameter that can be designed into PEM films to
enhance its microbicidal activity as PEM films can be built on virtually any type of surfaces of
various shapes and sizes.
Of course there have also been PEM films that are developed to release antibiotics over a
period of time; antibiotics (e.g., gentamicin, vancomycin, etc.) have been incorporated into
biocompatible PEM films that erode under physiological conditions (37*C, pH 7.4). " "
Unfortunately, one of the biggest issues with release of small hydrophilic drug is controlling its
release over extended periods of time; for example, the film developed by Chuang et al. was
unable to control the burst release of gentamicin at early times resulting in all the drugs being
released in less than 24 hours. 14 Recent improvement in the architecture of the film by
Moskowitz et al. shown release of the drug over weeks, but the initial burst release is still
present. 2
Most of the bactericidal coatings developed thus far involve leaching a bactericidal agent
into the environment; this may not be a desirable trait especially when the leached agent is toxic
to us as well. Especially with antibiotics, the likelihood of generating resistance strains of
bacteria is high when compared to antimicrobial materials designed to kill microbes on contact;
however, the release of a bactericidal agent sometimes is beneficial, especially when there is a
serious infection when a high dosage is needed to eradicate the infection, preventing the
infection from spreading.
1.2.2 Layer-by-Layer Applications in Drug Delivery
PEM films can be easily incorporated on the surfaces of medical implants to provide
localized drug delivery. 2 These PEM films can be tuned to release these therapeutic agents under
specific conditions, such as under physiological conditions (37*C and pH 7.4), presence of
enzymes, 2 or just via simple diffusion. Also, since usually the amount of material incorporated
into PEM films increases with the number of layers deposited, the amount of material loaded is
highly tunable. Tunable dosage in drug delivery is a very attractive characteristic because
currently many treatment options overload the body with the hope of a small amount of the drug
being delivered to a specific area of the body. The possibility of localized drug delivery with
PEM films opens up many new applications in the biomedical area, especially in the treatment of
cancer, as most of the chemotherapy drugs are harmful to the noncancerous cells.
The first generation drug delivery using PEM film has focused on diffusion based
delivery of drugs; drugs are deposited in nondegradable PEM films, and the drugs are released
via simple diffusion. This often results in a burst release of the drug at early times, followed by
residual release of drug and the entire release ending in just a few hours. Since this process is
diffusion controlled, there is no way of tuning the delivery time or dosage from these
nondegradable films. This issue brought about the idea of degradable films where the release of
the drug is based more on surface erosion of the PEM film rather than drug diffusing through the
nondegradable PEM film. 3,14,63 An example of this system is shown in Figure 1-2 where the
release of multiple agents are illustrated; the agent deposited closest to the top of the degradable
film theoretically will release first, followed by the next agent underneath it and so on.
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Figure 1-2: Multiagent release from a degradable thin film (Note: thickness of film and substrate
are not drawn to scale).
One of the most attractive degradable polymers for the design of these multiagent PEM
films is poly (1-aminoesters) (PBAEs). Lynn and Langer first considered these polymers for
applications in gene transfer vectors. 64, 65 Figure 1-3 shows the step-growth Michael-type
addition of a bis (secondary amine) monomers to diacrylate esters, to form the three PBAEs:
Polymer 1, 2, and 3.
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Figure 1-3: Synthesis and structure of poly(p-aminoesters), polymer 1, 2, and 3."
These polymers have been found to be highly biocompatible and noncytotoxic, so are
their degradation products. 65 They are cationic at physiological pH (7.4), thus can be
hydrolytically degraded because of the presence of ester bonds on the polymer backbone. The
polymer will degrade over time in aqueous environment. Poly 1 has been shown to effectively
incorporate and release model drugs, heparin etc. for nearly 17 hours at physiological pH. 63
Lysozyme (a model protein), " and gentamicin (an antibiotic), " diclofenac (an anti-
inflammatory) 3 have also been shown to effectively incorporate and release from these
degradable films in a surface erosion governed manner. Research in Hammond Lab at MIT has
shown that longer release times of dextran sulfate were observe with increasing hydrophobicity
of the PBAEs; the increase in hydrophobicity of the PBAEs made it more difficult for water to
cleave the ester bonds on the PBAEs backbone, thus delaying the surface erosion of the PEM
film; however, increasing the hydrophobicity above a threshold value causes rapid release of
dextran sulfate. Phase segregation and bulk film destabilization occurred beyond this threshold
value of hydrophobicity. Drug release times ranged from few hours up to twelve days using
PBAEs of various degree of hydrophobicity. 66
In order to consider PEM film as drug delivery system, some of the important factors that
need to be considered are: sequential delivery of drugs, time span of delivery, and incorporation
of a wide range of drugs. One of the unresolved problems of these PEM films is interdiffusion
between the layers of the film. In reality, the layers in the PEM film are highly interpenetrated
and interdiffusion of the loaded agents actively occurs. " Due to the long dipping time required
in LbL assembly, previously deposited layers can diffuse through the swelled film, rather than
being kinetically locked in place. Interdiffusion in the film leads to nonsequential release of
drugs in the film. Several solutions have been proposed to solve this problem; some of them
include using higher molecular weight polymer, and the use of barrier layers. 67 The use of less
time intensive LbL assembly techniques such as misting, 49,68 or spin coating 69 are also likely to
help rectify this issue.
1.3 Current Research in Permanent Microbicidal Coatings
A new, non-releasing antimicrobial system has emerged recently from the Klibanov Lab
at MIT. This approach utilizes a positively charged hydrophobic polymer at a particular
molecular weight and charge to kill bacteria. This polymer can either be covalently attached
(first-generation) 70 or "painted" onto surfaces using a cotton swab (second-generation). 71 The
first generation coatings involve covalently attaching the long hydrophobic polymeric chain to a
material surface; the polymers investigated include poly (4-vinyl-N-hyxylpyridinium) (N-hexyl-
PVP) and N, N - hexyl, methyl poly (ethylenimine) (N, N - hexyl, methyl PEI), as shown in
Figure 1-4. The second generation coatings use non-covalent hydrophobic interaction (like oil
paints) to create these microbicidal coatings; the hexyl moieties in the polymer is replaced with
dodecyl moieties to greatly increase the intermolecular hydrophobic interactions to make sure
that the polymer does not leach from the surface. It has been shown in a previous paper that if
the N, N - hexyl, methyl- PEI is used in the "painting" process instead of the N, N - dodecyl,
methyl-PEI (Figure 1-4), the polymer leaches from the surface. " These polymers have been
tested against some of the most common pathogenic bacteria (S.aureus and E.coli) and influenza
viruses, and thus far the most effective polymer in killing both bacteria and viruses is the linear
N, N - dodecyl, methyl-PEI (DMLPEI) (Figure 1-4). " The proposed mechanism for killing
bacteria for this polymer is by rupturing the bacterial cell membranes. Bacterial cell membrane
has a net negative charge; so there is an initial electrostatic interaction between the positively
charged surface and the bacterial cell membrane. Next, the hydrophobic side chains can then
diffuse through the lipid membrane undermining their integrity. "'74 Preliminary cytotoxicity of
this polymer against mammalian cells has also been tested; mammalian cells toxicity had been
tested using COS-7 cells where cell viability has been shown to decrease moderately for both
control and painted wells although painted wells have lower viabilities compared to control. '5
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Figure 1-4: Schematic representation of A) poly(4-vinyl-N-hexylpyridinium), and B) branched N-
hexyl, N-methyl - polyethylenimine as first generation microbicidal coatings. C) linear N, N -
dodecyl, methyl-poly(ethylenimine) "paint" as second generation microbicidal coatings.
Some of the disadvantages of the "painting" process used to make these microbicidal
coatings are that it cannot be used to coat geometrically complicated objects easily and since the
polymer is adhering to the surface via hydrophobic-interactions, there may be possibility that the
coating will peel off easily from the surface. It also leaves oily residue on the surface painted.
In this thesis work, the linear N, N - dodecyl, methyl PEI polycation is incorporated into PEM
films using the LbL technique. Contrary to the previous discussed "painting" technique, these
PEM films are held together by electrostatic interactions, and are usually robust and adhere to
surfaces very well. Plus, this technique has the ability to coat substrates of various geometries
conformally, and they are also only nanometer in thickness, as opposed to the "painted" film,
which are on the order of micrometer in thickness. 31,75
Contact killing antimicrobial surfaces other than the ones developed in Klibanov
laboratory have also been investigated. Chemical vapor deposition (CVD) and deposition of
PEM film via LbL assembly are two ways of creating multifunctional coatings. Previously,
researchers have demonstrated that vapor phase (CVD) and solution phase synthetic platforms
(LbL assembly) can be integrated to create multifunctional coatings, such as surfaces that are
both hydrophobic and antimicrobial. 76 LbL films built with polyallylamine and poly(4-styrene
sulfonate) have been shown to be bactericidal; 7" although the resultant films show high activity
against Gram positive bacteria, they are not as effective against Gram negative bacteria. Recent
studies have also reported various successful covalent attachments of polymeric microbicidal
materials onto various surfaces (e.g., glass, paper, metal, etc.); 78,79 in most of the cases, the
biocidal polymer contained cationic groups, such as quaternary ammonium salts (QAS) 79.82 or
alkyl pyridinium. 73,78,83 Covalent attachment usually involves a multi-step synthesis process
involving various chemicals; in this thesis work, the simple LbL assembly is used to incorporate
the antimicrobial polycation into a PEM film to impart a surface with antimicrobial property.
1.5 Thesis Overview
In this thesis, the groundwork for designing a multifunctional platform film technology
for use as surface coatings for various medical applications is established. This film technology
will impart a surface with long-term resistance towards biofilm formation via a permanent
microbicidal base coating and tunable release of therapeutic agents via a completely degradable
LbL top film for added medical functionality. Also, the microbicidal film presented in this thesis
work has been shown to resist protein adsorption from undiluted blood plasma as well; this anti-
fouling property of the film is an added bonus on top of the microbicidal functionality that the
film already possess. I think that this platform film technology is broadly applicable and
versatile enough to satisfy various thin films medical implant coating applications. In addition,
the microbicidal / antifouling film itself can also be applied to various practical applications
including commonly handled objects (e.g., keyboards, doorknobs, elevator buttons, etc.),
filtration membranes, food packaging, and many more.
Though several methods exist in constructing thin film coatings, only layer-by-layer
deposition allows molecular control over morphology of films necessary to achieve subtle
surface film properties to maximize the microbicidal and antifouling properties. Films built with
this method are in the nanometer range and the surface properties of the films can be tailored by
changing the polymers, and/or assembly conditions during buildup.
In chapter two, the fabrication rules and design parameters to create the permanent
microbicidal films were explored. In chapter three, a multifunctional film technology combining
the microbicidal film with controlled release of drugs via a degradable LbL film was
investigated. In chapter four, the antifouling property of the permanent microbicidal film was
extensively investigated. Finally, in chapter five, the mechanism in which the microbicidal film
kills bacteria and inactivate influenza viruses were examined via electron microscopy and
various other methods. The efforts put into this thesis work have laid the foundation for future
work involving the multifunctional platform film technology, especially in moving the
technology towards commercialization.
Chapter 2: Design of Permanent Contact Killing
Microbicidal Films using Layer-by-Layer (LbL) Technology
Reproduced in part with permission from "Bactericidal and Virucidal Ultrathin Films
Assembled Layer by Layer from Polycationic N-alkylated Polyethylenimines and Polyanions"
by Wong, S. Y., Li, Q., Veselinovic, J., Kim, B. S., Klibanov, A. M., Hammond, P. T.
Biomaterials 31 (14), 4079-4087, 2010. 10.1016/j.biomaterials.2010.01.119, @ 2010 Elsevier
2.1 Introduction
Everyday items handled by people (e.g., doorknobs, handles, keyboards, and elevator
buttons) are inhabited by various bacteria and viruses, some of which can spread disease. If such
objects could be made microbicidal without altering their functionality and appearance,
additional means of managing the spread of disease would result. Bacteria such as
Staphylococcus aureus and Escherichia coli are among the most common human pathogens, and
the rise of their antibiotic-resistant strains, e.g., methicillin-resistant S. aureus (MRSA), has
become a serious problem. Furthermore, annually 5% to 20% of the U.S. population is infected
with the influenza (flu) virus; as a result, over 200,000 people are hospitalized and about 36,000
people die each year. " The flu problem is even more serious when a new strain of the virus,
such as the so-called swine flu (HlNl), becomes infectious to humans. Many bacterial and viral
diseases can spread from person to person via contact with commonly handled objects; therefore,
if their surfaces can be made bactericidal and virucidal, the extent of this spread would be
reduced. In particular, eliminating live bacteria on surfaces of medical implants, thus preventing
biofilm formation would be a major advancement in the biomedical field.
Existing bactericidal coatings typically incorporate microbicidal agents like silver ions, "'
55,59 antibiotics, or other drugs, 84 that leach into the environment. A disadvantage of this
approach is that the embedded agents will eventually be exhausted, leading to limited functional
lifetimes. Furthermore, leachable coatings are not desirable when the leached microbicidal agent
is toxic or can lead to resistant microbes.
Recently, a new, non-releasing microbicidal strategy has been developed. 72,78,85-87 This
approach utilizes hydrophobic polycations, either covalently attached as a result of a multi-step
derivatization procedure or deposited (painted) onto surfaces to disrupt the bacterial membranes
and inactivate influenza viruses on contact. 53,73,88,89 Although the hydrophobic polycations can
be physically applied to surfaces from solution, 72 this "painting" process cannot easily coat
geometrically complex surfaces and at least micron-thick films are required for maximal
bactericidal activity. ' Also, these polymeric films can peel off or be scraped off the surface. To
address these potential shortcomings, in the present study we employed the layer-by-layer (LbL)
self-assembly approach. 31'91
With LbL technology, surfaces of various shapes can be coated with conformal ultra-thin
films whose surface properties can be systematically controlled through film composition and
morphology. ' 52 LbL technology involves sequential adsorption of multivalent species
(molecules, polymers, nanoparticles, etc.) with complementary functional groups utilizing
electrostatic or other non-covalent interactions, such as hydrogen bonding. 32,47,92 Owing to its
ease of application and low environmental impact, LbL technology has found a broad range of
applications, including biomedical materials, 14, 47, 93 membranes and electrodes for energy
applications, 6'7' 94 and electro- or magnetoresponsive surfaces. 9-11,95
LbL films are sensitive to assembly (pH and ionic strength) conditions; as a result, their
structure and composition depend on the film building process. 38 In addition, the film structure
can also be modified post-assembly by exposing the film to conditions different from those used
during film assembly. For example, LbL films built from polyallylamine and poly(4-styrene
sulfonate) could be made bactericidal by manipulating assembly and post-assembly pH
conditions (i.e., lowered pH). Although the resultant LbL films polyelectrolytes result in high
activity against Gram positive bacteria, they are not as effective against Gram negative bacteria.
Although other bactericidal LbL films have been developed, most of them work by incorporating
and releasing such bactericidal agents as silver ions, 3, ss,5s,96 quaternary ammonium salts, "
titania, 56 chitosan, 57'97 antibiotics, 2,4,14 antimicrobial peptides, 98 and enzymes. '5 LbL films
have also been designed to limit adhesion and viability of bacteria by modifying the chemical
and physical properties of the surface. 61
In this work, we demonstrate that by incorporating polymeric hydrophobic quarternary
ammonium salts with high bactericidal activity into LbL films, we can harness the potential of
these polycations, while achieving high and broad-spectrum bactericidal activity in nanometer-
scale coatings. Finally, we report the first use of LbL films to inactivate influenza virus.
2.2 Materials and Methods
2.2.1 Synthesis of Polymers
Poly(2-ethyl-2-oxazoline) (M. of 500 kDa), 1-bromododecane, l-bromohexane, 1-
bromobutane, iodomethane, tert-amyl alcohol, and other chemicals and solvents were from
Sigma-Aldrich. Linear NN-dodecyl-methyl-PEI (DMLPEI) was synthesized as previously
described. "' In short, linear PEI (LPEI) (M, of 217 kDa) was produced by deacylation of
poly(2-ethyl-2-oxazoline); " the resultant LPEI was dissolved in water, precipitated with
aqueous KOH, filtered, and washed repeatedly with water. The resultant deprotonated LPEI was
then alkylated first with 1-bromododecane (96 hr at 95*C) and then with iodomethane (24 hr at
60*C) to produce the end product DMLPEI. Syntheses of linear NN-hexyl-methyl-PEI
(HMLPEI) and linear NN-butyl-methyl-PEI (BMLPEI) were similar, except that LPEI was
alkylated with 1-bromohexane (24 hr at 95*C) and 1-bromobutane (24 hr at 95'C), respectively.
As for NN-dimethyl-PEI (MMLPEI), LPEI was alkylated by addition of iodomethane for 24 hr
at 60*C. The structures of these polymers are depicted in Figure 2-lA.
PAA (Mw of 50 kDa; Polysciences) was also used to acylate the -NH 2 group of dopamine
(DOPA; Sigma); 15% of the carboxyl groups of PAA were functionalized with DOPA (Figure
2-IB).
2.2.2 LbL Film Assembly
LbL films were assembled on rectangular 2.5 cm x 3.0 cm silicon substrates (Silicon
Quest International) with a programmable Carl Zeiss HMS slide stainer. Substrates were first
plasma-etched in oxygen using a Harrick PDC-32G plasma cleaner on high RF for 1 min and
then immediately immersed into a solution of a 1 mg/ml of polycation dissolved in an organic
solvent for at least 10 min. Most of the polycations used in this work only dissolve in organic
solvents: DMLPEI was dissolved butanol, HMLPEI in propanol, and BMLPEI in propanol.
MMLPEI was the only polycation that was soluble in water. The LbL film was built up by
alternating the deposition of a polycation and a polyanion; the latter included PAA, poly(Na 4-
styrene sulfonate) (SPS, M, of 70 kDa; Sigma-Aldrich), poly(Na vinyl sulfonate) (PVS; Sigma-
Aldrich), poly(methacrylic acid) (PMA, M, of 100 kDa; Polysiences), and poly(styrene-alt-
maleic acid) (PSMA; M, of 350 kDa; Sigma Aldrich). The polycation solutions used for film
construction were at a concentration of 1 mg/ml. Solutions of PAA, PAA-DOPA, PMA, and
PSMA used were at a concentration of 2 mg/ml in 0.1 M sodium acetate buffer, pH 5.1. PAA,
PMA, and PSMA solutions at pH 3.0 and pH 7.0 were pH adjusted using 1 M HCl and 1 M
NaOH, respectively. SPS and PVS solutions were at 2 mg/ml in 0.1 M NaCl and in deionized
water, respectively.
LbL films with the bilayer architecture of (Polycation/Polyanion)n was built, where n is
the number of bilayers and polycation and polyanion could be any of those mentioned above. A
bilayer would include a deposition of a layer of a polycation, followed by a layer of a polyanion;
for example, a 1.5 bilayer film will have a complete bilayer deposited, followed by a layer of
polycation on top. The following program was used to build up a bilayer: 20 min of dipping in a
polycation solution, followed by three rinses in the organic solvent used to dissolve the
polycation (1 min, 30 s, and 30 s, respectively), then three rinses in deionized water (1 min, 30 s,
and 30 s, respectively), followed by a 20 min dipping in a polyanion solution, then three rinses in
deionized water and three rinses in organic solvent (Figure 2-1C). This program was repeated
until the desired number of bilayers was obtained. To be subjected to acid treatment, the built
LbL films were immersed in pH 2.5 water for 3 hr, rinsed vigorously in three separate rinses of
deionized water, and dried gently with nitrogen gas.
2.2.3 LbL Film Characterization
Thicknesses of LbL films were measured using a spectroscopic ellipsometer (Woollam
M-2000D) and verified using a surface profilometer (KLA Tencor P-16). The surface
morphology and roughness of the LbL films were observed using an atomic force microscope
(Nanoscope I1a; Digital Instruments) in tapping mode and a scanning electron microscope
(JEOL 6320-HR).
Fourier transformed infrared (FT-IR) spectra of (DMLPEI/PAA)50 films with PAA at pH
3.0, 5.0, and 7.0 were acquired using a Nexus 6700 FT-IR (Thermo-Nicolet). Films with such
large number of bilayers (50) were used to acquire the data because films typically investigated
in this work (less than 4.5 bilayers) did not have sufficient material for the spectrophotometer to
detect.
2.2.4 Airborne Bacterial Assay
The bacterial strains used herein were S. aureus (ATCC, 25923) and E. coli (E.coli
genetic stock center, CGSC4401). Bactericidal activities of the LbL films were tested based on a
previously developed protocol. 1" Briefly, S. aureus was grown overnight in cation-adjusted
Mueller Hinton Broth II (CMHB) (Difco, BD) and diluted to 5 x 106 cells/ml. The diluted
bacterial suspension was sprayed onto samples (~10 ml/min) using a gas chromatography
sprayer (VWR International, cat. No. 21428-350); samples were incubated at room temperature
for 2 min, placed in a Petri dish, and covered with a slab of solid growth agar made from CMHB
media and BactoAgar (Difco, BD). The Petri dishes were incubated overnight at 37*C and
bacterial colonies on the surface of the samples were counted by hand if there were a few
colonies; alternatively, ten digital images per sample were taken with a 4X objective using a
microscope (Axioskop 2 MAT microscope, Carl Zeiss), and the total number of colonies was
extrapolated to the whole area of the sample. The same procedure was used for E. coli except
that it was grown overnight in LB-Miller broth (VWR), diluted to 5 x 10' cells/ml, and the agar
plates used to incubate the samples were made of 1% LB agar (VWR). Bactericidal activity was
calculated by comparing the number of colonies on negative control slides and on the samples.
Negative controls used were cleaned silicon substrates. Positive controls were silicon substrates
painted with a solution of 50 mg/ml DMLPEI dissolved in butanol as described previously.
2.2.5 Waterborne Bacterial Assay
S. aureus was grown overnight at 37"C in cation-adjusted Mueller Hinton Broth II
(CMHB) (Difco, BD); the culture was then centrifuged at 2,700 rpm for 10 min, washed,
resuspended in deionized water, and diluted to 106 cells/ml. LbL films coated substrates were
then incubated with the resultant solution at room temperature for 2 hr to promote bacteria
adhesion onto the surface. Samples were rinsed thrice in deionized water and incubated under a
solid slab of agar (Difco BD) overnight at 37*C. Bare Si substrate was used as the negative
control. The same procedure as in the airborne assay was used for counting the bacterial
colonies on the samples and controls. The results were presented as a colony density, which is
defined as average number of colonies on sample/average number of colonies on silicon control
times 100%; therefore, the colony density of a Si substrate control was always equal to 100%. 7
2.2.6 Determination of Virucidal Activity
The influenza virus strain used was A/WSN/33 (HINI); the virus was grown in the
Madin-Darby Canine Kidney (MDCK) medium from ATCC. 7 The protocol to test the samples
for virucidal activity was that described previously. 10 Briefly, a sample was placed in a Petri
dish and a 10 W droplet of a virus solution (-1.6 x 10' pfu/ml) was placed in the center of the
sample; a sandwiched system to spread the virus droplet was formed by putting a plain silicon
substrate on top of the sample. This system was incubated at room temperature for 30 min; then
the top substrate was lifted, and the virus droplet exposed sides were washed thoroughly with
PBS. Lastly, a plaque assay was performed to determine whether the samples were effective in
inactivating the virus. The virucidal activity was determined by comparing the virus titers
obtained from plaque assay of the negative control substrate and of the sample (these control
samples were the same as described above for determining bactericidal activities).
2.2.7 Adhesion and Non-leaching Test of LbL Films
The mechanical integrity of the film on surfaces was tested using a 3M Scotch tape which
was attached to the film and then removed in one motion. The test was performed on
(DMLPEI/PAA3.0)45 films. The thickness and bactericidal activities of the films before and
after the test were measured.
A modified Kirby-Bauer assay described previously was used to test samples for non-
leachability: 14 a sample coated side down was placed on S. aureus streaked agar plate and
incubated overnight at 37*C.
2.2.8 In-vitro Cytotoxicity Assay
Murine pre-osteoblast cell line MC3T3 (ATCC) was seeded on coated (with
(DMLPEI/PAA3.0),. or (DMLPEI/PAA3.0) 2.5) and non-coated glass substrates (control) placed
in wells of a 6-well plate. 100,000 cells/well was incubated for 24 hr and then labeled with
live/dead fluorescent stains (Live/Dead Viability/Cytotoxicity Kit for mammalian cells;
Invitrogen). A series of 10 digital images were taken of cells at lOx magnification using a
fluorescence microscope (Axioskop 2 MAT microscope, Carl Zeiss). The numbers of live and
dead cells were counted on each sample, and the percentage of cell viability was computed
relative to control.
2.3 Results and Discussion
2.3.1 Airborne Bactericidal Activity of LbL Films
The polycations used to build the LbL films in this study (Figure 2-1A) varied in
hydrophobicity with the length of their N-alkyl chain; in contrast to the polyanions used (Figure
2-1B), these polycations were insoluble in water and thus were dissolved in butanol or propanol.
The microbicidal activity of the LbL films was examined as a function of the polyanion and the
pH of the polyanion aqueous solution during assembly. The polyanion charge density and
whether its monomer was a weak or a strong acid, was anticipated to be important because the
interactions between the polyelectrolytes govern the availability and density of the positive
charges and the conformation of the hydrophobic groups on the surface.
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Figure 2-1: A) Structure of microbicidal polycations with various alkyl chain lengths (n = 1, 4, 6,
and 12); B) Structure polyacrylic acid (PAA) and dopamine (DOPA) used for acylation between
amine group of DOPA and carboxylic group of PAA; C) Schematic of the modified LbL dipping
process that alternates between an organic solvent for the polycation and an aqueous solution for
the polyanion.
Because LbL assembly typically involves alternation between aqueous solutions, a modified
version of the LbL protocol that involved dipping from an organic polycation solution, followed
by solvent and then aqueous rinses was introduced, as described in the Experimental Section.
Figure 2-2 depicts the growth curves and roughness of (DMLPEI/PAA)n films built with PAA
solutions at pH 3.0 and 5.0. The films exhibit an initial lag growth phase (thickness not
significantly increasing) studied extensively in the LbL literature, 101 followed by a linear growth
beyond 4.5 bilayers. The roughness data for the (DMLPEI/PAA), films (Figure 2-2) show that
for films up to 4.5 bilayers, the thickness and roughness values were statistically the same (from
4 to 10 nm), supporting the initial patchy growth period reported by others. " As the number of
bilayers was increased further, however, the roughness of the film grew. We observed that the
bactericidal activity of (DMLPEI/PAA5.O)n films rose with increasing number of bilayers; 100%
bactericidal activity was achieved at 14.5 bilayers of (DMLPEI/PAA)n built with PAA at pH 5.0.
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Figure 2-2: Growth curve and roughness of (DMLPEI/PAA). prepared with A) PAA at pH 3.0, and
B) PAA at pH 5. 0 showing initial patchy growth of the films, and linear growth beyond 4.5 bilayers.
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We then investigated the dependence of bactericidal activity on the pH of the PAA
solution used during film assembly. As seen in Figure 2-3, by adjusting the pH of the PAA
solution used for film deposition the level of bactericidal activity of the films can be changed
significantly, achieving complete bactericidal activity with only 1.5 bilayers of deposition for
(DMLPEI/PAA)n with PAA at pH 3.0. We can thus achieve the same level of activity as the
microbicidal "painted" films (micron thick) with a much thinner (~10 nm) LbL film using the
same microbicidal polycation, DMLPEI. Because the degree of ionization of weak polyacids is
highly pH-dependent, the conformation of the PAA chains should also change from a relatively
flat and thin random coil at high pH to chain arrangements that take on loops, coils, and brushes
forming thicker layers when less charged at low pH. 102,103 Figure 2-2 shows that LbL films built
with PAA at pH 3.0 are thicker than those built at pH 5.0.
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Figure 2-3: Activities of (DMLPEI/PAA). LbL films against airborne bacteria; 1.5 to 4.5 bilayers films
built with PAA at pH 3.0, 5.0, or 7.0.
When only one layer of the DMLPEI (0.5 bilayer of the film) was deposited on a
negatively charged Si wafer, no bactericidal activity was observed. This observation is likely
because the negatively charged plasma-treated surface of the Si wafer induced deposition of the
DMLPEI layer as a surface-conformal coating, with many of the positive charges tightly
associated with the surface negative charges and thus little brush layer generated at the surface.
When a PAA at pH 3.0 layer was then deposited, followed by another layer of DMLPEI thus
producing a (DMLPEI/PAA)15 film, the bactericidal activity of the film jumped dramatically to
100% (Figure 2-3). This observation is in agreement with results reported in literature finding
that the conformation of the previously adsorbed layer greatly affects the conformation of the
next polymer layer. 38,102 In this case, having a weakly charged PAA layer yields the subsequent
DMLPEI layer with a thicker and loopier brush-like architecture with many of its positive
charges available to interact with bacterial cell membranes. Note that only the pH of the
polyanion solution could be changed because the polycation used was dissolved in an organic
solvent.
The finding that the bactericidal activity of our LbL films against S. aureus, increases as
the pH of PAA solution used for assembly is lowered (Figure 2-3) is consistent with the current
view that mobile positive charges plus hydrophobic alkyl chains of a certain length are necessary
for bactericidal activity. 53,77,88,104,los5It is believed that there are initial electrostatic interactions
between the cationic surface and the negatively charged bacterial cell membranes; subsequently,
the hydrophobic alkyl chains can diffuse through the lipid bilayer, thus undermining the integrity
of the membrane and eventually leading to the death of the bacteria. Previous research has also
shown that multiple positive charges are required to permeate cell membranes; 106 the
arrangement, accessibility, and mobility of these charged groups on the surface are important as
well. '0 A schematic illustrating the likely conformations of the PAA chains and the
microbicidal polycation chains is depicted in Figure 2-4A. A transition is observed from thicker
and more brush-like PAA layers at low pH that leave more available positive charges on the
surface for interaction with the bacterial cell membrane to flat, highly charged PAA layers at
higher pH that undergo greater electrostatic interactions with DMLPEI. FT-IR spectra showed in
Figure 2-4B support this proposed trend. LbL films made from PAA at pH 3.0, 5.0, and 7.0,
showed decreasing intensity of the COOH acid band (C=O stretching of COOH, v = 1710 - 1700
cm') and concomitantly increasing intensity of the COO- band (asymmetric stretching band of
COO-, v = 1565 - 1542 cm-) as the pH of PAA is increased (Figure 2-4B).
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Figure 2-4: A) Schematic representation of the change in conformation of the polymer chains as the
pH of the PAA solution used during film assembly is increased. At pH 3.0, the PAA chains are
mostly uncharged resulting in a more loopy chain conformation of the polycation DMLPEI, with
most of its positive charges available to interact with bacterial cell membranes. As the pH of the
PAA solution is increased, the PAA chains become more negatively charged, resulting in more ionic
cross-linking with the DMLPEI chains, thus decreasing their number of available positive charges
for interaction with bacterial cell membrane; B) FT-IR spectra of (DMLPEI/PAA)5s films with PAA
at pH 3.0, 5.0, and 7.0 during film assembly. Two distinct bands of the carboxylic acid group of PAA
were observed: asymmetric stretching band of COO- (v = 1565 - 1542 cm-), and C=O stretching of
COOH (v O = 1710 - 1700 cm 1).
Our films were found effective against both the Gram positive S. aureus and the Gram
negative E. coli bacteria (Figure 2-5). The difference in the composition of the cell walls of
these two types of bacteria should influence the way that positive charges coupled with
hydrophobic alkyl chains interact with them. 108 Gram positive bacteria have a simple cell wall
consisting of a thick peptidoglycan layer, while Gram negative bacteria have cell walls made out
of a lipopolysaccharide layer, a thin peptidoglycan layer, and the periplasmic space. 109 This
extra lipopolysaccharide layer is apparently capable of protecting Gram negative bacteria,
making it harder to kill them using just positive charges. "0 In addition, Gram negative bacteria
have been shown to change their outer membrane composition to provide extra protection when
in contact with quaternary ammonium compounds. '" Therefore, to exert a broad spectrum
bactericidal activity, both positive charges and hydrophobic alkyl chains, as exist in our LbL
films, appear necessary.
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Figure 2-5: Bactericidal activity of 1.5 to 4.5 bilayers (DMLPEI/PAA). films against S.aureus and E.
coIl.
To further test the view that having mobile positive charges is important for enhanced
bactericidal activity, we subjected (DMLPEI/PAA)n films built from PAA solution at pH 7, to
water at pH 2.5, as previously investigated by Lichter and Rubner, who subjected (SPS/PAH),
films to a low pH, and saw an increase in bactericidal activity of their films. 77 Figure 2-6 shows
that the bactericidal activity of our films increases after exposure of the films to low pH; when
the films are exposed to a low pH, some of the carboxylate (COO-) groups on the PAA chains are
protonated to carboxylic (COOH) groups, resulting in conformational changes to the PAA
chains, and consequently, the DMLPEI chains. 8 Ultimately, the polymer chains become more
mobile with the lowered charge of the PAA chains, leading to less ionic crosslinking with the
positive charges on the DMLPEI chains. Thus not only surface coverage (increasing with the
number of bilayers) but also the number of mobile positive charges is important for the
bactericidal activity of the LbL films.
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Figure 2-6: Activity of (DMLPEI/PAA). films prepared at pH 7.0 before and after pH treatment.
Indeed SEM and AFM images of the films taken before and after the pH treatment
(Figure 2-7) reveal that the surface coverage increases, suggesting rearrangements of looser
polycationic chains. After the pH treatment, the roughness of the film decreased from 4.72 ±
1.20 nm to 2.08 ± 0.87 nm. These data indicate that treating (DMLPEI/PAA). films built
originally with PAA at pH 7.0 post-assembly with a pH 2.5 aqueous solution raised the
bactericidal activity of the films, although not to the level of the films originally built at a low pH
(namely, PAA solution at pH 3.0); thus the ionic cross-linking within the LbL films is only
partially reversible.
C D
Figure 2-7: SEM images of (DMLPEI/PAA) 2.5 films prepared at pH 7.0 A) before and B) after pH
treatment, showing the increase in coverage of the film post pH treatment. AFM images (10 pm x
10 pm scan) of (DMLPEI/PAA) 4.5 films prepared at pH 7.0 C) before and D) after pH treatment,
also showing more uniform coverage of the film after low pH treatment; z-scale = 25 nm.
By modifying PAA with dopamine (DOPA), the number of carboxylate (COO-) groups
available to form ionic bonds with DMLPEI's positive charges is effectively reduced and the
bactericidal activity is increased (Figure 2-8). Functionalizing PAA with DOPA, which reduces
the charge density of the PAA chains, presumably results in a loopier PAA chain conformation,
as in the case of films built with PAA at low pH assembly conditions, thereby influencing the
conformation of the next adsorbed DMLPEI layer and yielding a brush-like layer.
There are also indications of interpenetration between the polyelectrolyte layers in the
LbL films discussed here. For example, for the (DMLPEI/PAA) 2and (DMLPEI/PAA)5 films, it
did not matter whether PAA or DMLPEI was the topmost layer (Figure 2-8). Instead of forming
well-stratified layers, those formed within the LbL films interdigitate, as is typical for
polyelectrolyte multilayers. 36
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Figure 2-8: Comparison of activity of 1.5 to 5.0 bilayers (DMLPEI/PAA). (prepared at pH 5.0) and
(DMLPEI/PAA-DOPA). films (also at pH 5.0); figure also shows the comparison of activity of a 1.5 and
2.0 bilayers film and a 4.5 and 5.0 bilayers fim illustrating the activities of films with either DMLPEI or
PAA as the top most layer. All films were tested with S. aureus.
We also found that the bactericidal activity of the LbL films was influenced by the
hydrophobicity of the polycation, i.e., the length of its alkyl chains. Using PAA solutions at pH
3.0 and pH 7.0 and polycations with various alkyl chain lengths (Figure 2-9), we found that the
bactericidal activity against S. aureus varied significantly on the alkyl chain length. For
example, films built with linear NN-dimethyl-PEI (MMLPEI, n=1) and NN-butyl,methyl-PEI
(BMLPEI, n=4) were significantly less bactericidal than those built with NN-hexyl,methyl PEI
(HMLPEI, n=6) and DMLPEI.
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Figure 2-9: Films (1.5 bilayers) were built with polycations of various alkyl chain lengths ranging from
methyl (n = 1) to dodecyl (n = 12), with PAA as the polyanion (pH 3.0 and 7.0).
To examine the activity against Gram negative bacteria, for which the size of the alkyl
chain is thought to be critical, 7" films made with BMLPEI and MMLPEI as polycations, and
PAA at pH 3.0 and pH 7.0 as polyanions were tested against E. coli. The bactericidal activity
against E. coli was found to be lower compared to that against S. aureus for n < 6 (Figure 2-10).
In addition, films built using either linear or branched non-alkylated PEI as a polycation and
PAA (at pH 3.0), were impotent against both bacteria. Therefore, hydrophobicity, along with a
high positive charge density, is necessary for bactericidal activity.
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Figure 2-10: 1.5 bilayers MMLPEI (n=1) or BMLPEI (n=4) films built with PAA at either pH 3.0 or
pH 7.0 were tested against S. aureus and E. coi
Next we examined the dependence of bactericidal activity of the LbL film built with
DMLPEI as the polycation on the strength of the acid in the polyanion used. Films built using
strong polyacids as poly(4-styrenesulfonate) (SPS) and poly(vinylsulfonate) (PVS) displayed no
bactericidal activity. Because strong polyacids are highly ionized, most of the positive charges
on the DMLPEI chains should be tightly bound to their negative charges resulting in few mobile
positive charges available to disrupt bacterial cell membrane. This effect persisted even when
salt was added to the sulfonated polyion solution to reduce the polyanion-polycation electrostatic
attraction via ionic screening.
Another interesting observation was that the hydrophobicity of the weak polyacid used
for film assembly affected the bactericidal activity as well (Figure 2-11). While LbL films built
with a slightly more hydrophobic poly(methacrylic acid) (PMA) had similar bactericidal activity
as those built using PAA, with a much more hydrophobic poly(styrene-alt-maleate) (PSMA) the
bactericidal activity dropped significantly. The bulky styrene groups of this strong polyacid
could change the polyanion-polycation interaction changing the presentation of the polycation on
the surface and also interact with the DMLPEI's alkyl chains preventing them from functioning
as "brushes" on the surface, thus decreasing the activity of the films.
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Figure 2-11: Films were built with DMLPEI and three polyanions of varying hydrophobicity; all films
were 1.5 bilayers.
2.3.2 Activity of LbL Films Against Waterborne Bacteria
Next we explored the possibility of using our microbicidal LbL films as permanent
coatings for biomedical implants to prevent bacterial attachment in aqueous environments. To
this end, 1.5 bilayer and 2.5 bilayer (DMLPEI/PAA)n films built at pH 3.0, 5.0, and 7.0 were
tested against waterborne S. aureus and found to be effective in preventing bacterial attachment
onto the surface relative to a bare silicon substrate control. As seen in Figure 2-12, the films
made at pH 3.0 were most effective in preventing bacteria from attaching to the surface, which is
in agreement with our aforementioned airborne results.
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Figure 2-12: Activity of LbL films against waterborne S. aureus comparing colony density on a
bare silicon control with that on either a 1.5 or a 2.5 bilayer (DMLPEI/PAA). films; PAA was at pH
3.0, 5.0, or 7.0; Colony density on control slide is 100%.
2.3.3 Virucidal Activity of LbL Films
The most bactericidal LbL films were tested against Influenza A/WSN/33 (HINI) virus.
This virus has an outer lipid envelope 112 which may be vulnerable to the high density of positive
charges and hydrophobicity presented on the LbL surfaces (as was the case with surfaces
"microbicidally painted" with DMLPEI .,. 3).
A 1.5 bilayer (DMLPEI/PAA3.0). film was found to be 60% virucidal (Figure 2-13),
although it was 100% bactericidal. However, the virucidal activity of the LbL films increased as
we increased the number of bilayers, and reached 100% beyond 7.5 bilayers. Since the size of a
viral particle (~100nm) is at least 10 times smaller than that of a bacterium (~1ptm), the
incomplete virucidal activity seen with our films at a lower number of bilayers may be due to the
voids on the surface that are large enough to fit a virus but too small for a bacterium (Figure
2-14).
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Figure 2-13: Virucidal activity of the (DMLPEI/PAA). LbL films prepared from PAA at pH 3.0
against influenza A/WSN/H1N1 virus.
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SEM images of the initial layers of our films show that as the number of bilayers
increases, the surface coverage of the films increases (Figure 2-14A). At a lower number of
bilayers, there are areas on the surface not covered by the film; this patchiness can enable a virus
particle (~100 nm) to land on bare surface regions and thus not be inactivated. This bare spot is
too small to fit a bacterium (~1 pm), thus 100% bactericidal activity is achieved even for films
with low numbers of bilayers.
Figure 2-14: A) SEM images of 2.5 and 7.5 bilayers (DMLPEI/PAA). films prepared from PAA at
pH 3.0, showing the increase in surface coverage of films with increasing number of bilayers; B)
Relative size of a bacterium to a virus particle.
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2.3.4 Cytotoxicity, Non-leaching and Adhesion Tests of LbL Films
To test the safety of our microbicidal LbL films, we observed mammalian cell viability
when seeded on coated surfaces. To this end, an in-vitro cytotoxicity assay with Murine pre-
osteoblast cells (MC3T3) was performed with (DMLPEI/PAA) 5 and (DMLPEI/PAA), 5 films
formed at pH 3.0 using an uncoated substrate as control. The cell viability on our films was
found to be indistinguishable from that on the uncoated surface, indicating that there is no
apparent cytotoxicity associated with our films from this study (Figure 2-15).
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Figure 2-15: Cell viability on uncoated versus film-coated substrate, showing no apparent
cytotoxicity on the films.
The proposed mechanism for microbicidal action of DMLPEI is via a direct disruption of
the microbes' membrane by hydrophobic polycationic chains upon contact with the film. 74 To
establish whether our LbL films also kill on contact, rather than by leaching the polycation, a
modified Kirby-Bauer assay was performed. 14 No zone of inhibition was detected beyond the
film boundaries (Figure 2-16) and only bacteria directly in contact with the film were killed.
Figure 2-16: Non-leaching test with a (DMLPEI/PAA) 1.5 LbL film prepared from PAA at pH 3.0 on
an agar plate streaked with S. aurues. No zone of inhibition is seen beyond the boundaries of the
film. Cloudy white area is covered with bacteria colonies.
Finally, attaching a strip of 3M Scotch tape onto the surface of the film and removing it
quickly in a single motion tested the mechanical integrity of our LbL films. The films before and
after this experiment were tested for bactericidal activity against S. aureus. We observed no
change in the activity of the (DMLPEI/PAA) 4. films, built with PAA at pH 3.0, demonstrating
their mechanical robustness. We also observed no difference in the measured film thickness
before and after the adhesion test (20.3 nm ± 1.5nm).
2.4 Conclusions
We demonstrated herein that microbicidal functionality could be imparted onto surfaces
using LbL technology by using the right combination of polycations and polyanions, as well as
assembly and/or post-assembly conditions. We found that LbL films that are as thin as 10 nm
were lethal to both airborne and waterborne Gram positive and Gram negative bacteria, as well
as to a strain of influenza virus. Our films were effective in preventing bacterial attachment to
surfaces, and thus indicate promising properties for prevention of biofilms on surfaces. While
highly microbicidal, the LbL coatings were also found to be non-cytotoxic to a mammalian cell
line based on cell viability assay. Coupled with their mechanical robustness, these properties
bode well for practical potential of our LbL films where microbicidal and virucidal
functionalities are required.
Chapter 3: Multifunctional Polyelectrolyte Multilayer
Platform Film Coating Technology for Various Medical
Implant Applications
Reproduced in part with permission from "Dual Functional Polyelectrolyte Multilayer
Coatings for Implants: Permanent Microbicidal Base with Controlled Release of Therapeutic
Agents" by Wong, S. Y., Moskowitz, J. S., Veselinovic, J., Rosario, R. A., Timachova, K.,
Blaisse, M. R., Fuller, R. C., Klibanov, A. M., Hammond, P. T. J Am Chem Soc, 132 (50),
17840-8, 2010. 10.1021/ja106288c, @ 2010 American Chemical Society
3.1 Introduction
Recently, there has been great interest in developing drug-device combinations for
medical applications, "4 including cardiovascular prostheses, 19,20 orthopedic implants, 2,21 stents,
22 biosensors, 115 and electrical leads. 116 The primary causes of implant failures, adverse foreign
body response (FBR) and implant-related infection, could benefit from such combination
therapies. FBR is initiated by protein adsorption onto the surface, which can trigger an
inflammation cascade as a wound healing response to protect the body from foreign objects and
may lead to fibrous encapsulation of the implanted device. 24, 1' Localized delivery of anti-
inflammatory agents is still the most effective way to control inflammation and subsequent
fibrosis. " Medical devices can thus be designed in combination with anti-inflammatory agents
to achieve direct delivery to the surrounding tissues. Implant-associated infections can occur on
any implanted medical device from minimally invasive contact lenses, to temporary urinary
catheters and endotracheal tubes, to permanent cardiac valves and orthopedic implants. 20
Pathogens are generally introduced to the implant surface by exogenous organisms on the skin,
non-sterile surgical tools, or the local environment. Again, by designing the medical device with
microbicidal functionality should reduce the infection rate. Perhaps most importantly, systemic
bacteria circulating in the bloodstream can spontaneously become pathogenic upon attachment to
the implant surface at any time (even years) after implantation. This necessitates a drug-device
combination that yields long-term prevention of bacterial attachment while being capable of
eliminating pre-existing infection. Thus due to considerable benefits from the use of drug-device
combinations, the design of a robust platform to incorporate additional therapeutic value into
existing medical implants is compulsory.
Implant failure due to device-associated infection adds up to approximately 1 million
cases annually. 119 Of these, catheter-associated urinary tract infection accounts for about 40% of
all nosocomial infections 10 and orthopedic implant-related infections ring up close to $2 billion
in annual treatment procedures despite their lower infection rate. 119 Regardless of the implant
type, the basic pathogenic mechanism for infection is that of bacterial colonization of the device
surface, which can lead to the development of a biofilm, a matrix of sessile bacteria consisting of
about 15% bacterial cells by mass and 85% hydrophobic exopolysaccharide fibers. 2 Biofilms
can damage surrounding tissues and generate planktonic bacterial cells spreading infection. 26
The biofilm environment protects the bacteria from being easily targeted by normal therapeutic
levels of antibiotics. 26,121
Current engineering approaches to biofilm control include the use of drug-device
combinations that elute antibiotics locally in an effort to eradicate planktonic bacteria before
biofilm formation and employ ultrasonic energy 122 or weak DC field 123 to disrupt an existing
biofilm, hence making it more susceptible to standard treatment. As the search for biofilm-
resistant materials continues, the release of local antibiotics from implant surfaces remains the
most common strategy for prevention; however, the standard release kinetics of many antibiotic-
releasing systems is problematic. Generally, the initial burst-release phase is efficacious in
achieving eradication of an existing infection; however, this is often followed by a monotonically
decreasing rate of elution that eventually exposes any persistent bacteria to sub-lethal
concentrations of antibiotic, hence allowing the development of resistant strains. In theory,
having a permanent microbicidal surface coating that does not lose its functionality would
prevent bacterial attachment and thus biofilm formation.
Polyelectrolyte multilayer (PEM) films have been studied extensively for applications in
drug delivery. 3,14,15 They can be easily incorporated onto the surfaces of implants to provide
controlled and localized drug delivery of therapeutic agents. In the present work, films are
constructed using the layer-by-layer (LbL) deposition technique, " in which oppositely charged
species are adsorbed sequentially onto an initially charged substrate. PEM films are simple and
economical to fabricate and can be built on most geometries with nanometer scale control over
thickness and surface properties. 31,33 Consequently, the amount of material loaded is highly
tunable, which is attractive for drug delivery because many treatment regimens overload the
body with drug in hope that a small amount of it will actually be delivered to a specific area of
the body. Owing to its versatility, LbL technology has been applied to a broad range of fields
including drug delivery, 2,3,14,47,92,93 membranes and electrodes for energy applications, 6,7,94 and
electro- or magneto-responsive surfaces. 9-11,95
Previously, we have demonstrated the use of hydrolytically degradable polycations in
multilayers for both sustained and designed substantive bolus release of small-molecule drugs
from surfaces. 2, 3 Here we present a bifunctional film technology made of a permanent
microbicidal PEM thin film combined with a hydrolytically degradable PEM film capable of
incorporating and releasing various therapeutic agents. This architecture imparts the surface of
the implant with a microbicidal base film "4 that is biofilm-resistant, with the added advantage of
either a bolus delivery of an antibiotic to eradicate infection 2 or sustained delivery of an anti-
inflammatory drug to minimize FBR at the implant site 3 as two examples demonstrating the
versatility of this platform technology. While previous works have demonstrated multiple
functionality in a single construct, 53,125 thin film technology that exhibits highly adaptable dual
functionality, such as long-term biofilm prevention with tunable release of various therapeutic
agents depending on the application at hand, as presented in this work, is rare. Most previous
dual-action antimicrobial systems exhibit diffusion-based release of a biocide (e.g., silver
nanoparticles) and contact-killing or bacteria-repelling capabilities. 53, 125 Therefore, the
constructs proposed in this work are promising as next-generation surface coatings for implants.
3.2 Materials and Methods
3.2.1 Materials
Poly(2-ethyl-2-oxazoline) (M. = 500 kDa), 1-bromododecane, iodomethane, tert-amyl
alcohol, poly(acrylic acid) (PAA; Mn = 239 kDa), poly(sodium 4-styrenesulfonate) (PSS; M, =
70 kDa), 3 M sodium acetate buffer (NaOAc; pH 5.2), as well as solvents and common buffers,
were from Sigma-Aldrich (St. Louis, MO). PAA (M. = 50 kDa) and linear polyethylenimine
(LPEI; Mn= 25 kDa) were from Polysciences (Warrington, PA). 1,4-Butanediol diacrylate, 1,6-
hexanediol diacrylate, and 4,4-trimethylenedipiperidine were from Alfa Aesar (Ward Hill, MA).
Poly (carboxymethyl-p-cyclodextrin) (PolyCD) was from CTD (High Springs, FL). Diclofenac
Na salt was from TCI America (Portland, OR) and gentamicin sulfate (GS) and phosphate-
buffered saline (PBS; pH 7.4, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4) from Mediatech,
Inc. (Herndon, VA). Tritium-labeled gentamicin (3H-GS; 250 pCi total, 1 mCi/mL in ethanol,
200 pCi/mg) was from American Radiolabeled Chemicals (St. Louis, MO). Silicon wafers (test
grade n-type) were from Silicon Quest (Santa Clara, CA). Cation-adjusted Mueller Hinton Broth
II (CMHB) and BactoAgar were from Difco BD (Franklin Lakes, NJ). Alpha minimum essential
medium (a-MEM), fetal bovine serum (FBS), penicillin/streptomycin solution, fluorescein-
conjugated albumin from bovine serum (BSA), MTT (tetrazolium [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay kit, and Live/Dead Viability/Cytotoxicity kit for
mammalian cells were all from Invitrogen (Carlsbad, CA). Bovine plasma (IBV-N) was
purchased from Innovative Research (Novi, MI). All reagents were used without further
purification.
3.2.2 Synthesis of Polymers
Poly($-amino ester)s Poly 1 and Poly 2 (structures shown in Figure 3-1) were
synthesized as previously described. 65 Briefly, a solution of 4,4-trimethylenedipiperidine (34.1
mmol) in 50 mL of anhydrous tetrahydrofuran (THF) was added to the diacrylate monomer (34.1
mmol) dissolved in an equal volume of the same solvent. The reaction mixture was purged with
nitrogen and stirred for 48 h at 50*C. Afterwards, the reaction mixture was cooled to room
temperature and precipitated into cold hexanes. Polymers were collected via filtration.
Linear NN-dodecyl,methyl poly(ethyleneimine) (DMLPEI; structure shown in Figure
3-1) was synthesized as previously described. 1 In short, LPEI (M. of 217 kDa) was produced
in house by deacylation of 500 kDa poly(2-ethyl-2-oxazoline); 99 the product was dissolved in
water, precipitated with aqueous KOH, filtered, and washed repeatedly with water. The resulting
deprotonated LPEI was alkylated first with 1-bromododecane (96 h at 95'C) and then with
iodomethane (24 h at 60*C) to produce DMLPEL. Polymers were collected and dried under
vacuum prior to NMR analyses
3.2.3 Preparation of Polyelectrolyte Solutions for Film Deposition
Solutions of Poly1, Poly2, GS, and PAA were prepared at 2 mg/mL, and PolyCD at 20
mg/mL in 0.1 M NaOAc. Diclofenac powder was dissolved into the PolyCD solution to achieve
a final concentration of 1.4 mg/mL, thus yielding complexation of diclofenac with polyCD.
Dipping solution of DMLPEI was prepared at 1 mg/mL in 1 -butanol. Poly 1, GS, and PAA
solutions were adjusted to pH 5.0 while those of Poly2 and PolyCD to pH 6.0. For films used in
release experiments, the GS solution was spiked with 5 pL of 3H-GS per 50 mL of dipping
solution yielding a 0.1 pCi/mL product without significantly changing the concentration of the
GS dip bath. LPEI and PSS dipping solutions were prepared at 2 mg/mL in water and adjusted
to pH 4.25 and 4.75, respectively, with 1 M NaOH and 1 M HCl. All solutions were prepared
with water from a Milli-Q Plus (Bedford, MA) at 18.2 MQ.
3.2.4 LbL Film Assembly
As previously described, 124 LbL films were assembled on silicon substrates using a
programmable Carl Zeiss HMS slide stainer. Substrates were cleaned with methanol and ultra
pure water, dried under N2, and plasma-etched in 02 using a Harrick PDC-32 G plasma cleaner
on high radiofrequency for 1 min, and then immediately immersed into the first polycation
solution (i.e., DMLPEI or LPEI) for at least 10 min. Samples were prepared with nondegradable
bilayers of either the bactericidal DMLPEI/PAA or the non-bactericidal LPEI/PSS. For the
former, a cascade rinse cycle of three butanol rinse baths (1 min, 30 s, 30 s), followed by three
water baths (1 min, 30 s, 30 s) was used after deposition of DMLPEI, and the reverse cycle of
water then butanol after PAA. For the latter, a cascade rinse cycle of three water baths (10 s, 20
s, and 30 s) was used after each polyelectrolyte dipping.
For combination films incorporating PolyCD complexed with diclofenac (PolyCD-DIC),
10 bilayers of (DMLPEI/PAA)n were deposited first, 124 followed by deposition of bilayers of
(Poly2/PolyCD-DIC), (where n denotes the number of bilayers), as previously described. 3 The
architecture (DMLPEI/PAA),O(Poly2/PolyCD-DIC) 20 was used for drug release and film
degradation studies. For characterization of the growth of (Poly2/PolyCD-DIC)n films on top of
(DMLPEI/PAA)IO films, (Poly2/PolyCD-DIC)n films with n = 5, 10, 15, 20, and 30 bilayers were
built (Figure 2).
As for the combination film incorporating GS, (Poly 1/PAA)5 was first deposited onto
(DMLPEI/PAA),o to facilitate uniform buildup of subsequent GS-containing films. Then
deposition of the tetralayer architecture (Polyl/PAA/GS/PAA)n was performed as previously
described.2 Films with (DMLPEI/PAA)IO(Polyl/PAA)5(Poly1/PAA/GS/PAA) 2 were used for
drug release and film degradation studies. Characterization of the growth of
(Poly1/PAA/GS/PAA)nfilms on top of (DMLPEI/PAA)IO(Polyl/PAA)5 films, was done with n =
5, 10, 15, 20 and 30 (Figure 2). As a control in the efficacy studies comparing films with the
bactericidal base layer functionality (i.e., (DMLPEI/PAA)IO) to those without bactericidal
functionality, the architecture (LPEI/PSS)IO(Polyl/PAA/GS/PAA) 20 was used.
3.2.5 Characterization of Film Growth, Degradation and Drug Release
After film deposition, all films were allowed to air dry. For film growth, thicknesses of
the (DMLPEI/PAA)IO(Poly2/PolyCD-DIC)n films were measured using a spectroscopic
ellipsometer (Woollam M-2000D). All thickness measurements were made at five different
points on each film and averaged over three separate films. Roughness measurements of films
were generated using a surface profilometer (KLA Tencor P-16). Thickness measurements of
films were verified using the surface profilometer. In the case of
(DMLPEI/PAA)IO(Polyl/PAA)5(Polyl/PAA/GS/PAA), combination films, both thickness and
roughness measurements were performed by profilometry at four predetermined locations per
film using a Veeco Dektak 150 surface profiler and averaged over three separate films.
For drug release and degradation studies with diclofenac combination films, samples
were stored at 4*C until use. All measurements were conducted in triplicates. For drug release,
each (DMLPEI/PAA)IO(Poly2/PolyCD-DIC) 20 film was immersed in 1 mL of in a sealed
microcentrifuge tube and incubated at 37*C to simulate physiological conditions. At each time
point, each film was moved into a new tube with 1 mL of fresh PBS; released drug was
quantified with fluorescence spectroscopy (Quantamaster Fluorimeter; PTI, Lawrenceville, NJ).
Film degradation was also performed at 37*C in PBS; at various time points, each film was
removed, dried under N2, and thickness measured using a spectroscopic ellipsometer at five
different points on the surface of the film. Immediately after measurement, each film was re-
immersed in PBS and resealed.
For drug release experiments with combination films incorporating GS, samples were
immersed into 20 mL of PBS in a tightly capped Falcon tube maintained at 37*C. Degradation
environments were kept sealed to minimize evaporative loss. A 1 mL sample was extracted
from the Falcon tube at each predetermined time point and mixed with 5 mL of ScintiSafe Plus
50% (Fisher Scientific, Atlanta, GA) prior to GS quantification. The resulting mixtures were
analyzed using a Tricarb Model 2810 TR liquid scintillation counter (Perkin Elmer, Waltham,
MA). The raw data in disintegrations per minute (DPM) were converted directly to pg of drug
using the DPM value for the dipping solution (2 mg/mL). Total release from the film at the ith
timepoint was calculated by the following equation:
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where m, (pg) is the the total cumulative mass of GS released from the film at the time of
measurement i, C, (pg/mL) is the concentration of sample i (which is multiplied by the total
volume V, remaining in the Falcon tube as of the ith measurement), and the summation term adds
up the total extensive quantity of gentamicin removed in each of the i-1 former aliquots.
Accompanying degradation experiments were conducted by immersing samples into 10 mL of
PBS in a tightly capped Falcon tube maintained at 37*C. At each time point, films were
removed from the PBS and allowed to air-dry. All dry state thicknesses were determined via
profilometry at four locations and averaged over at least three films.
3.2.6 Determination ofActivity of Diclofenac Released from Film
In order to determine whether the diclofenac released from
(DMLPEI/PAA)IO(Poly2/PolyCD-DIC) 20 was still active, a cyclooxygenase (COX) enzyme
inhibition screening kit was purchased from Cayman Chemicals (Ann Arbor, MI). This assay
measures the amount of the highly fluorescent compound resorufin, which is a product of the
reaction between hydroperoxy endoperoxide prostaglandin G2 (PGG2) and 10-acetyl-3,7-
dihydroxyphenoxazine (ADHP). Presence of a COX inhibitor (i.e., diclofenac) would reduce or
eliminate the production of resorufin; hence activity of diclofenac can be correlated to the
amount of resorufin produced. Samples from the temporal drug release experiment were assayed
against control samples containing no drug, 44 VM drug, and uncomplexed PolyCD (i.e., no
diclofenac). The assay was performed according to the manufacturer's specifications.
3.2.7 Bactericidal Activity of Films
The bacterial strains used herein were Staphylococcus aureus (S. aureus; ATCC 25923)
and GS-resistant S. aureus (ATCC 33592). After complete degradation of (Poly2/PolyCD-
DIC) 20 , the bactericidal activity of the underlying (DMLPEI/PAA) 0 film was tested using a
mediaborne assay "4 and Kirby-Bauer assay, 14 each as previously reported. All experiments
were done in triplicate.
Briefly, for the media-borne assay, S. aureus was grown overnight at 370C in CMHB.
The culture was then centrifuged at 2,700 rpm for 10 min, washed, resuspended in fresh CMHB
media, and diluted to 106 cells/mL. Film-coated substrates were compared to blank Si controls
by incubating with the bacterial broth at room temperature for 15 min, 30 min, 1 h, and 2 h
promoting bacterial adhesion onto the surface. Samples were rinsed thrice in fresh CMHB
media and incubated overnight at 370C under a solid slab of agar made from CMHB media and
BactoAgar. In the separate long-term experiment, bacterial solution was incubated at 37*C with
either bare Si, or (DMLPEI/PAA)10, or (DMLPEI/PAA)10 (Poly2/PolyCD) 20 in separate Petri
dishes for a period of two weeks. The pH of the bacterial growth medium was about 7.4, which
promoted the degradation of the (Poly2/PolyCD)20 film on top of the (DMLPEI/PAA)IO film.
Every three days, the solution in each Petri dish was refilled with 2 mL of fresh CMHB media to
replace fluid loss due to evaporation in the incubator, and to provide fresh nutrient for the
bacteria to thrive. After the two weeks, each sample was removed and rinsed three times with
fresh medium to remove any nonspecifically bound bacteria from the surface. Each sample was
then incubated under a slab of agar overnight and bacteria colonies counted as described earlier.
In a separate experiment, to determine if protein adsorption would compromise the
microbicidal activity of (DMLPEI/PAA)IO films, the films and blank silicon substrates were
incubated in 100 Rg/mL fluorescein-conjugated albumin solution at 37*C for 1 h. Films were
then removed, rinsed thrice in fresh PBS, and imaged via fluorescent microscopy. Films and
blank substrates were also incubated in bovine blood plasma at 37*C for 1 h. Both sets of
samples were further tested with the mediaborne assay detailed earlier using the 2 h incubation
time.
For Kirby-Bauer assay, S. aureus was grown overnight at 370C in CMHB; agar plates
were then streaked with exponentially growing S. aureus at 10 cells/mL. Blank Si,
(DMLPEI/PAA)IO, (DMLPEI/PAA)IO(Poly2/PolyCD-DIC) 20, and (DMLPEI/PAA)IO after
complete degradation of (Poly2/PolyCD-DIC) 20 were placed film side down on the agar plates
and incubated overnight at 370C.
For films releasing GS, Kirby-Bauer assays were performed with S. aureus comparing
blank Si, contact-killing (DMLPEI/PAA)IO, release-killing (LPEI/PSS)IO(Polyl/PAA/GS/PAA) 20,
and dual functional (DMLPEI/PAA)IO(Polyl/PAA)5(Polyl/PAA/GS/PAA) 20 after increasing
degradation times of (Polyl/PAA/GS/PAA) 20. Zones of inhibition (ZOI) were imaged. To
further distinguish the unique functionality of the nondegradable, contact-killing
(DMLPEI/PAA)IO surface, a GS-resistant strain of S. aureus was used to perform a separate
Kirby-Bauer assay.
3.2.8 Quantification of Blood Plasma Adsorption Using Quartz Crystal Microbalance (QCM)
A Masscal G1 (quartz crystal microbalance) was used for quantification of protein
adsorption onto surface of the microbicidal base film relative to an uncoated crystal. Film was
deposited onto 1-inch quartz crystals (5-MHz frequency) with gold electrodes (Tangidyne Corp.,
SC). The frequency of the blank crystal was recorded before film deposition; frequency of the
film-coated crystal was recorded again after film deposition (dried with N2). Both blank and
film-coated crystals were then incubated in bovine blood plasma (density of approximately 1,025
mg/mL) at 37*C for 1 h; the crystals were then rinse thrice in fresh PBS then dried with N2. The
frequency of the crystals was recorded again after protein adsorption. Upon protein adsorption,
the oscillatory motion of the crystal declined, and the decreased resonant frequency was
measured. The Sauerbrey equation was used to relate the change in frequency to mass adsorbed
per unit area (17.7 ng cm-2 Hz-' for 5-MHz crystals). 126 Although the Sauerbrey relation (for
rigid layer) is not strictly true for adsorption of protein due to viscoelastic property of the protein
adlayer, it can be used as an approximation to compare relative amounts of protein adsorbed
between the blank and film-coated crystals. The experiments were done in triplicate.
3.2.9 In-vitro Cytotoxicity Assay: Adhesion and Proliferation of Cells
Films were tested with human pulmonary epithelial cancer cells (A549), murine pre-
osteoblast cells (MC3T3-E1), and murine macrophage cells (Raw264.7) which were seeded on
(DMLPEI/PAA)I0 or uncoated glass slides. In all cases, cells were grown in a-MEM
supplemented with 10% FBS and 1% penicillin/streptomycin at 37*C with 5% CO2. Substrates
were placed in the bottom of 6-well plates and each well seeded with 150,000 cells and 3 mL of
media. To investigate cell adhesion to the surface of our films, two sets of experiments were
performed in parallel: cells in media with FBS and without FBS. Cells were cultured for 6 h on
substrates, and cell adhesion investigated by examining morphology by light microscopy; for
metabolic activity (via MTT assay), the cells were cultured on samples for 3 h in normal growth
media, and 3 h in growth media containing 10% MTT. Substrates were transferred to new 6-well
plates to quantify only those cells which were adherent to the substrate. One mL of dimethyl
sulfoxide was added to solubilize the resulting purple formazan crystals, 100 pL aliquots from
each sample were placed into a 96-well microtiter plate, and absorbance was measured at 570 nm
with a 690 nm correction. All samples were measured in triplicate. Cell metabolic activity was
calculated relative to the negative control (uncoated glass slide). Proliferation experiments
requiring the same experimental procedure were conducted on the same set of films at days 1, 3,
and 7 in FBS-enriched media.
3.3 Results and Discussion
3.3.1 Design of Combination Films with Dual Functionality
We set forth to design a dual functional combination film technology that is highly
adaptable and broadly applicable to various thin film medical device coating specifications. The
charged multilayer film components, shown in Figure 3-1, include poly (acrylic acid),
degradable poly (p-amino ester)s (PBAEs), charged poly (cyclodextrins) complexed with
diclofenac (PolyCD-DIC), and linear NN-dodecyl,methyl-poly(ethylenimine) (DMLPEI).
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Figure 3-1: A) Structure of hydrolytically degradable poly(p-amino ester)s, Polyl and Poly2. B)
Structure of microbicidal linear NN-dodecyl,methyl-PEI (DMLPEI). C) Poly(acrylic acid) (PAA).
D) Schematic of poly(p-cyclodextrin) with drug sequestered in the interior of its monomer unit, as well
as a close-up structure of a monomeric P-cyclodextrin. E) Structure of diclofenac.
The dual functional LbL films consisted of a thin permanent (nondegradable)
microbicidal base film, (DMLPEI/PAA) 0 , and a hydrolytically degradable top multilayer film
incorporating cationic poly(P-amino ester)s65 Polyl or Poly2 (Figure 3-lA) capable of releasing
various drugs. The efficacy and versatility of this dual functional film architecture was
demonstrated using two examples: (1) the small hydrophilic antibiotic gentamicin to eradicate
infection at an implant site, and (2) the small hydrophobic anti-inflammatory drug diclofenac to
assist with healing at the implant site. The permanent microbicidal base film was built up via
electrostatic interaction between the hydrophobic polycation DMLPEI and PAA as the
polyanion.
Poly(p-amino ester)s, such as Polyl and Poly2, can undergo hydrolytic degradation at
physiological conditions and have been incorporated into PEM films as an erodible component
for controlled release. 2-4, 14, 15, 66, 127 Hydrolytic degradation of the poly-(beta)-aminoesters is
impacted by access of water molecules to the hydrolyzable bond. Poly2, which has a longer
alkyl chain length than Polyl and hence a greater local hydrophobicity around the ester bond,
exhibits a slower rate of hydrolysis. 66 Diclofenac, which is a small aromatic molecule is
complexed with PolyCD, capable of sequestering hydrophobic drugs in the interior pockets of its
cyclodextrin groups, while the negatively charged exterior allowed for stable bilayer growth of
(Poly2/PolyCD-DIC)n. 3 Gentamicin (GS) is a water-soluble aminoglycoside with five
protonatable amine groups and therefore can be incorporated into PEM films; 2,14 however, since
both it and Polyl are positively charged at deposition conditions, a polyanion must be included
to build up a stable film via electrostatic interactions. PAA was chosen because it promotes
incorporation of a large quantity of GS into PEM films. 2 This results in a tetralayer film
architecture of (Polyl/PAA/GS/PAA).. These combination films, schematically depicted in
Figure 3-2, can be constructed with high loadings and designed to release gentamicin ex vivo and
in vivo for periods ranging from hours to weeks. 2 It is also possible to construct a GS-releasing
film with Poly2 instead of Polyl, and the same applies to the diclofenac releasing films. The
degradation and release kinetics of the film should be different, with faster release for a
(Poly1/PolyCD-DIC). film and slower release for a (Poly2/PAA/GS/PAA), one.
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Figure 3-2: Schematic representation of the combination fims in this work. A) Gentamicin releasing
(Poly1/PAA/GS/PAA)., and B) diclofenac releasing (Poly2/PolyCD-DIC). combination films, built on top
of the microbicidal (DMLPEI/PAA),0 .
3.3.2 Characterization of the Combination Films: Growth, Erosion, and Release
To characterize the hydrolytically degradable films built on top of the microbicidal base
film, three critical film characteristics were examined: growth, erosion, and release. The
thickness and roughness of the microbicidal base film (DMLPEI/PAA)IO - 26 ± 5 and 7 ± 4 nm,
respectively, - were measured before buildup of the erodible (Poly2/PolyCD-DIC), or
(Poly1/PAA)5(Poly1/PAA/GS/PAA). films. Ten bilayers were used in the base film to achieve
100% microbicidal activity and provide a uniform platform for buildup of the subsequent drug-
releasing layers. (DMLPEI/PAA), films had previously been shown to exhibit an initial lag
growth phase for which the film exhibited complete surface coverage only beyond 4.5 bilayers.
124 The thickness and roughness of the combination films of (DMLPEI/PAA)10(Poly2/PolyCD-
DIC), and (DMLPEI/PAA)10(Poly1/PAA)5(Poly1/PAA/GS/PAA)n were then measured, and their
growth curves are depicted in Figure 3-3A and Figure 3-3B. The (Polyl/PAA)5 adhesion layer
was deposited after the microbicidal base film to help initiate and facilitate uniform deposition of
the (Polyl/PAA/GS/PAA)n film. The (Polyl/PAA)5 adhesion layers increased the total thickness
and roughness of the growing film to 75 ± 18 and 30 ± 13 nm, respectively. Without the
intermediary layers of (Polyl/PAA)5 , we observed no film growth of (Poly1/PAA/GS/PAA)n
directly on top of (DMLPEI/PAA)10 .
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Figure 3-3: Thickness and roughness of A) (Poly2/PolyCD-DIC), and B) (Poly1/PAA/GS/PAA). films
(note difference in y axis scale). All films were made on top of base film (DMLPEI/PAA)IO.
We hypothesized that the hydrophobic nature of the highly interpenetrated
(DMLPEI/PAA)10 film (water contact angle of 85* ± 20) surface reduced the ability of the
hydrophilic GS molecules to wet and adsorb onto the surface. Adding the buffer layers (water
contact angle of 67* ± 30) provided a more hydrophilic surface and reservoir for GS molecules to
establish themselves within the film. Both sets of combination films exhibited linear growth;
films incorporating diclofenac had nanometer-scale thickness (average of 3 ± 1 nm per bilayer), '
as opposed to the much thicker GS-releasing films ( 0.50 ± 0.05 Pm per tetralayer on average).
Roughness of (DMLPEI/PAA)IO(Poly2/PolyCD-DIC)n films was relatively small compared to
the film thickness. The micron-scale thickness and roughness of the GS-releasing films reported
here had previously been observed; 2 we believe that this phenomenon is due to a significant
interdiffusion of small, polar GS molecules within the film architecture during assembly, as well
as both film dissolution and diffusion that occur during the deposition process. Futhermore, we
observed no turbidity in the dipping solutions throughout the fabrication process, which suggests
the absence of aggregates. The film thickness increases faster than the surface roughness during
film growth, and the roughness levels off at about 20 bilayers in both cases.
Having established that these combination films could be grown consistently and
controllably, their degradation characteristics were investigated in a physiologically relevant
environment (PBS, 37 *C). Degradation experiments were conducted with
(DMLPEI/PAA)IO(Poly2/PolyCD-DIC) 20  and
(DMLPEI/PAA)IO(Polyl/PAA) 5(Polyl/PAA/GS/PAA) 20  films. Diclofenac-releasing films
exhibited a linear degradation profile over a period of 10 days (Figure 3-4A), which is
characteristic for stable, surface-based erosion of degradable LbL films. 3 Degradation of GS-
releasing films was also linear, but complete film erosion occurred within three to four hours
(Figure 3-4B). The much faster erosion rate of the gentamicin-releasing film was due to the fact
that the small molecular size of GS allows out-diffusion of drug from the film and subsequent
destabilization of the assembled layers. For this reason, the mechanism for GS release is a
combination of rapid small molecule diffusion, followed by film destabilization and polymer
erosion. On the other hand, the (Poly2/PolyCD-DIC), thin films are composed of two
alternating polyelectrolytes that do not exhibit out-diffusion and for which the primary
mechanism of erosion is Poly2 degradation. As mentioned before, these combination films were
designed to provide sustained release of anti-inflammatory drug over days or bolus-style release
of antibiotics over hours to address an existing infection. The resulting degradation profiles
clearly align with the desired properties of each combination film.
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Figure 3-4: Degradation curves for A) (Poly2/PolyCD-DIC) 2o and B) (Poly1/PAA/GS/PAA)20 films (note
difference in x axis scale). All films were made on top of base film (DMLPEI/PAA)10.
Release studies were performed with the same film architectures as in the degradation
experiments. A major advantage of LbL systems is that the quantity of drug incorporated into
each film can be tuned according to the total number of deposited layers thus making the LbL
technology platform a versatile way to address many applications and drug delivery
specifications. Approximately 8 ptg/cm 2  of diclofenac was incorporated into
(DMLPEI/PAA)10(Poly2/PolyCD-DIC) 20, with sustained release over 10 days (Figure 3-5A).
The GS-releasing (DMLPEI/PAA)1O(Polyl/PAA) 5(Polyl/PAA/GS/PAA) 20 films incorporated
about 70 Ag/cm 2 of the antibiotic and released over a timeframe similar to film degradation, with
approximately 90% delivery during the first 2.5 h (Figure 3-5B); this burst release of antibiotic is
critical to address an existing infection at an implant site by preventing re-propagation and
biofilm formation. It should be noted that the underlying (DMLPEI/PAA),O(Polyl/PAA) 5 film,
without the topmost (Polyl/PAA/GS/PAA)20 film, can load 6.3 ± 0.8 [tg/cm 2 of GS via
absorption, showing that the small GS molecules are able to diffuse through the underlying
layers of film.
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Figure 3-5: Drug release curves for A) (Poly2/PolyCD-DIC) 20 and B) (Poly1/PAA/GS/PAA) 20 films (note
difference in x and y axis scales). All films were made on top of base film (DMLPEI/PAA)10.
3.3.3 Activity of Drug Released from Combination Films
To confirm that the diclofenac, which was complexed with polyCD was still active after
release, the inhibition of cyclooxygenase (COX) enzyme was investigated. COX is one of the
enzymes responsible for the formation of prostaglandins, which affect inflammation and rate of
return to homeostasis. 128, 129 As seen in Figure 3-6, release samples taken from a
(DMLPEI/PAA)10(Poly2/PolyCD-DIC) 20 film eluted from day 1 through day 9 (separate non-
cumulative released samples) were effective in inhibiting the activity of COX when compared to
the standard of uncomplexed diclofenac solution. This result showed that the activity of
diclofenac was not altered upon complexation with polyCD and can be maintained at levels
sufficient to achieve complete COX inhibition in cell assays. Previous studies have shown that a
significant amount of diclofenac released from this film construct remains complexed with
polyCD, followed by its slow dissociation into solution. 3
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Figure 3-6: Percentage of COX enzyme inhibition showing that diclofenac released from
(DMLPEI/PAA)lo(Poly2/PolyCD-DIC) 10 is still active. The released samples from day 1 to day 9
represent non-cumulative drug released from the film.
The microbicidal activity of the dual functional combination films with underlying
DMLPEI base layers, namely (DMLPEI/PAA)1 ((Poly1/PAA),(Poly1/PAA/GS/PAA) 2 , was
tested via Kirby-Bauer assays and compared to a control GS-releasing multilayer without an
underlying antimicrobial base, namely (LPEI/PSS)IO(Poly1/PAA/GS/PAA) 20 (Figure 3-7). Zones
of inhibition (ZOIs) were observed at 0 min, 15 min, and 2 days. Each time corresponds to the
duration for which the sample was immersed in phosphate buffered saline (PBS) at 37*C prior to
plating for the Kirby-Bauer assay. At early times (0 and 15 min), the ZOI of these two films are
nearly identical. After 2 days, a smaller ZOI exists around the combination films; however, the
control film no longer exhibits any ZOI. Since the microbicidal base film is non-erodible, it only
kills bacteria directly in contact with it; the ZOIs around the erodible GS films are the direct
result of GS released from the films, confirming its activity. As GS is eluted from the films, the
ZOI gradually decreases. There appears to be more GS available for elution in the combination
film, as observed by the ZOI at day 2, likely due to the added GS loading achieved via
absorption of GS into the microbicidal base layers and the intermediate Poly1/PAA layers used
to construct the film.
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Figure 3-7: Kirby-Bauer assays of gentamicin (GS) releasing films eroded for various time periods,
ranging from 0 min (as built) to 3 days; Row 1 represents GS films built on (LPEI/SPS)10 base films and
Row 2 those built on microbicidal (DMLPEI/PAA) 0 base films. Figure also shows a decrease in the size
of zone of inhibition as time increases.
3.3.4 Bactericidal Activity of the Permanent Microbicidal Base Film
After the hydrolytically degradable top films were completely eroded, the newly exposed
microbicidal (DMLPEI/PAA)IO base films were shown to be still efficacious against S. aureus
using Kirby-Bauer assays. Based on these assays and film degradation and elution curves, there
is no more drug eluting from the film at day 3. As seen in Figure 3-7, the 3-day samples with
the microbicidal base film show 100% direct contact killing of S. aureus; there is no ZOI
present, but the region underneath the film indicates no bacterial growth on the surface of the
substrate. On the other hand, the system with the standard base film of (LPEI/SPS)IO exhibits no
measurable efficacy in preventing bacterial growth on the surface relative to the uncoated silicon
substrates. To further distinguish the unique functionality of the microbicidal base film from that
of any remaining GS, a GS-resistant strain of S. aureus was used to determine the efficacy of a
completely eroded (DMLPEI/PAA)IO(Polyl/PAA) 5(Polyl/PAA/GS/PAA) 20  film versus
(LPEI/PSS)IO(Polyl/PAA/GS/PAA) 20 (Figure 3-8) after immersion in PBS at 37*C for four days.
The top row (left to right) of Figure 3-8 consisted of a bare silicon substrate and the
(LPEI/PSS)1O(Polyl/PAA/GS/PAA) 20 film following erosion for 4 days, while the bottom row
(left to right) consisted of a bare silicon substrate and
(DMLPEI/PAA)1 (Poly1/PAA)5(Poly1/PAA/GS/PAA) 20 eroded for 4 days. The 4-day released
film with the underlying microbicidal base film yielded 100% contact killing, with similar results
obtained for underlying (DMLPEI/PAA)10 films exposed after complete degradation of the
diclofenac-releasing films (Figure 3-9).
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Figure 3-8: Row 1 represents GS films built on (LPEI/SPS)10 base films and Row 2 those built on
microbicidal (DMLPEI/PAA)lo base films. Films eroded for 4 days and tested with GS-resistant
bacteria to confirm the microbicidal base film functionality; the result shows that the microbicidal
(DMLPEI/PAA)lo base film (bottom right sample) is effective in killing the bacteria, while the
(LPEI/SPS)lo base film (top right sample) is not.
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Figure 3-9: Similar results were obtained for (Poly2/PolyCD-DIC) 20(DMLPEI/PAA)10 films that had
been allowed to undergo complete drug release before testing, showing that microbicidal base film
remains active. Note that the dark (black) colored substrate surfaces are bacteria-free, while the lighter
beige colored substrate surfaces correspond to contamination by bacteria colonies (each dot
corresponds to a colony forming unit).
As mentioned earlier, biofilm formation on the surface of an implant is a major cause of
implant failure. Therefore, it is advantageous to prevent the formation of biofilms on the surface
of medical implants in the first place. To this end, (DMLPEI/PAA) 0 films with completely
eroded top films were tested against media-borne S. aureus and found to be effective in
preventing bacterial attachment relative to blank silicon substrates (Figure 3-10). These film-
coated substrates prevented colonization of their surfaces by bacteria for periods of time ranging
from 15 min to 2 weeks, whereas bacteria significantly colonized blank silicon substrates after
just a 15-min incubation.
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Figure 3-10: Mediaborne assay with S. aureus with increasing time of incubation in bacterial solution;
top row shows bare substrates completely colonized by bacteria (light beige colored dots); bottom row
shows (DMLPEI/PAA)10 films with degradable top films completely eroded with no sign of colonization
by bacteria (black colored substrate).
Another major issue with implants is protein adsorption from blood plasma onto implant
surfaces, initiating a foreign body response; this is a common problem with medical implants
which can happen within seconds of implantation2 3 and elicit inflammatory responses. 23,25, 130
Therefore, cells at the surface of biomaterials are not necessarily in direct contact with the
material itself. To test whether the microbicidal functionality of our base film would be
compromised by protein adsorption, (DMLPEI/PAA)10-coated quartz crystals and blank crystals
were incubated in solutions of bovine blood plasma for 1 h; the adsorption of protein was
quantified using quartz crystal microbalance (QCM), and we found that almost no protein was
adsorbed onto the surface of (DMLPEI/PAA) 0 coated crystals relative to blank crystals: 4.0 ±
1.0 pg/cm 2 on film-coated crystals versus 89.5 ± 14.2 pg/cm 2 on blank crystals (i.e. 22 times
more adsorption of protein on blank crystals). This result was further confirmed with adsorption
15 min
of fluorescently tagged albumin on film-coated and blank glass slides (Figure 3-11). No
albumin adsorption onto the surface of (DMLPEI/PAA)lo coated films was observed whereas the
blank glass slides were completely biofouled. This finding suggests that these films may prevent
at least some common protein adsorption, likely due to a combination of hydrophillic and
hydrophobic groups that present molecular-scale heterogeneities on the surface of the
(DMLPEI/PAA)n system. 131,132
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Figure 3-11: Fluorescently tagged albumin adsorption onto bare glass slide and (DMLPEI/PAA)10
coated glass slide.
The protein-treated samples and controls made on silicon wafers were tested with the
mediaborne assay (with a 2-h incubation time); film-coated substrates were still effective in
preventing bacterial attachment (95 ± 3 % clear), while the blank substrates were heavily
colonized (Figure 3-12). More importantly, protein-treated samples that were tested with the
mediaborne assay for a period of 2 weeks remained highly effective in preventing bacterial
colonization; 88 + 2% of the surface remained bacteria-free. Thus the permanent microbicidal
base film functionality was not heavily compromised even in the presence of blood plasma and
still prevented formation of biofilms.
Bare Substrate Film-Coated
Figure 3-12: Mediaborne assay with S. aureus comparing bare substrate and (DMLPEI/PAA)10 film
after incubation in blood plasma for 1 h. The bare substrate shows complete colonization by bacteria
(beige colored dots), while film-coated substrate remains uncolonized (black colored substrate).
3.3.5 Cytotoxicity, Adhesion and Proliferation of Cells on Films
To investigate the cytotoxicity and interaction of cells with our films, murine pre-
osteoblast cells (MC3T3-E1) and human pulmonary epithelial cancer cells (A549) were seeded
onto glass coated with (DMLPEI/PAA)IO and uncoated glass as a control. There was no
difference in cell adherence to film-coated substrates relative to uncoated glass slides in media
with or without serum (Figure 3-13). The use of serum-free media ensured that the cells were
exposed to the surface of the films and not a protein-coated surface. An MTT assay, which
measures metabolic activity of cells, was compared to cell morphology data and found to be
consistent. Cell viability on the permanent microbicidal films was indistinguishable from that on
blank glass slides, indicating no apparent cytotoxicity associated with these films.
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Figure 3-13: Cell viability of films relative to bare glass substrates indicating no apparent cytotoxicity of
the films. Cells were grown in media with or without serum. Note that the difference in cell
viability shown is not statistically significant (t-test p values of 0.36 and 0.84 for data with serum
and without serum respectively).
Cell proliferation was investigated with (DMLPEI/PAA)I0 films. MTT assays of cells
seeded and cultured on films for 1, 3, and 7 days show no difference in cell metabolic activity
compared to that on blank glass substrates (Figure 3-14), which was again consistent with cell
morphology observations (Figure 3-15). We have shown that while bacterial cells were not able
to colonize surfaces coated with our films even after a 2-week incubation in concentrated
bacterial solution, mammalian cells both attached and divided normally on the microbicidal
(DMLPEI/PAA)IO films.
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Figure 3-14: Viability of A549 (epithelial) and MC3T3 (osteoblast) cells on (DMLPEI/PAA)1 0 coated
glass slides after culturing for 1, 3, or 7 days.
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Figure 3-15: Proliferation (day 1, 3, and 7) of MC3T3-E1 cells on A) bare glass substrates and B)
(DMLPEI/PAA)10 films; proliferation of A549 cells on C) bare glass substrates, D) (DMLPEI/PAA)10.
Cytotoxicity of the films was also tested against a primary cell line, namely a murine
macrophage cell line (Raw264.7); cell metabolic activity (Figure 3-16) on the microbicidal film
was slightly lower when compared to cells seeded on bare glass substrate on day 1, day 3 or day
6. Previously, we found no difference in cytotoxicity when mammalian cells (i.e., osteoblasts and
epithelial cells) were seeded on the film-coated substrate relative to the uncoated substrate (Figure
3-14 and Figure 3-15); by using macrophages, one of the cell types involves in an immune response,
the cells can assess the cytotoxicity of foreign biomaterials more effectively.
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Figure 3-16: Cell viability of macrophages (Raw264.7) on bare substrate versus film-coated
(DMLPEI/PAA) 0 coated substrate on day 1, 3, and 6.
Cell proliferation pictures, as shown in Figure 3-17 also showed slightly higher density of
cells on bare glass substrates especially on day 3 and day 6; although both cell viability assay and
cell proliferation show slight cytotoxicity on the surface of the film-coated substrate, majority of cells
were still able to adhere and proliferate on the film surface.
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Figure 3-17: Proliferation of macrophages (Raw264.7) on bare glass (left column) and film-coated
glass (right column); A) and B) are day 1 pictures; C) and D) are day 3 pictures; E) and F) are day
6 pictures
3.4 Conclusions
The sustained capability of the underlying microbicidal film to resist biofilm formation,
even in the presence of highly resistant strains of bacteria, suggests the potential of these systems
as implant coatings. Here, we propose the use of the microbicidal base film (DMLPEI/PAA) 0 as
a long-term surface coating for medical implants to prevent bacterial attachment, with the added
versatility of tunable release of therapeutic agents via a degradable LbL top film to provide an
additional medical functionality. The combination film technology has been demonstrated in
this work with the paired use of an antibiotic-releasing or the diclofenac-releasing film to provide
localized drug delivery the implant site and treat an infection or minimize FBR by inhibiting the
formation of inflammatory mediators. When each film is gone, the microbicidal base film would
serve as a long-term implant coating preventing bacterial attachment and biofilm formation.
This dual functional platform film technology appears broadly applicable and versatile enough to
satisfy a variety of thin film medical device coating specifications.
Chapter 4: Mechanistic Investigation of Protein Resistance
in Microbicidal Polyelectrolyte Multilayer Films
Reproduced in part with permission from "Drastically Lowered Protein Adsorption on
Microbicidal Hydrophobic/Hydrophilic Polyelectrolyte Multilayers" by Wong, S. Y., Han, L.,
Timachova, K., Veselinovic, J., Hyder, M. N., Ortiz, C., Klibanov, A. M., Hammond, P. T.
Submitted to ACS Nano, @ 2011 American Chemical Society
4.1 Introduction
Biofouling can generally be described as an undesired attachment of biomolecules (e.g.,
proteins) or organisms (e.g., bacteria, algae, plants) on wetted surfaces in an aqueous
environment; this is a major problem in many applications, including biomedical implants, 20,24,
133 hospital equipment, 134 biosensors, 11, 13 food packaging, 29 water filtration membranes, 27
marine equipment, 28 in vitro diagnostics, 136 and so on. Protein adsorption on surfaces often
reduces the sensitivity and efficacy of the devices. In addition, protein adsorption, and the
subsequent formation of a layer of protein on surfaces, especially in biological implants, creates
an environment suitable for bacterial colonization, and eventually forms a biofilm. 24 The two
primary causes of implant failures are the adverse foreign body response (FBR) and implant-
related infection. FBR begins with protein adsorption onto the implant surface, which then
triggers an inflammation cascade as a wound healing response to protect the body from foreign
objects; this can eventually lead to fibrous encapsulation of the implanted device. 24,17 On the
other hand, implant-associated infections can happen on contact lens, catheters, prosthetic
devices, and orthopedic implants. 20 Current treatment methods for infection include surgical
replacement of the infected implant, along with broad-spectrum antibiotic therapy, often
incurring additional health care costs. 137 This becomes a serious concern when the infection is
caused by an antibiotic-resistant strain (e.g., methicillin-resistant Staphylococcus aureus
(MRSA)); 133,138 therefore, if surfaces can be made to simultaneously resist protein attachment
and bacteria colonization, the percentage of implant failure related to FBR and infection can be
drastically reduced.
Protein adsorption onto a surface is a complex and not well understood phenomenon;
broadly, it can be discussed in terms of two limiting mechanisms: adsorption by electrostatic
(charge-charge) interactions and hydrophobic interactions. Of course, a combination of these
two effects may occur, and other non-specific interactions via hydrogen bonding and dipolar
mechanisms also play a role. Currently, the few materials that effectively resist protein
adsorption from complex biological fluids include poly(ethylene glycol) (PEG), 139, 140
oligo(ethylene glycol) (OEG) self-assembled monolayers (SAMs), 141 zwitterionic-based
materials, 14 2 and various hydrophilic biomacromolecules (e.g., dextran, mannitol). 143, 144 It is
believed that long PEG polymers resist protein adsorption because of steric repulsive forces
when the chains are compressed by protein molecules approaching the surface; 145, 146 however,
PEG is susceptible to oxidation damage over time and loses its function in biological media. 141,
147 Recent studies show that OEG SAMs attract a tightly bound water layer around the OEG
chains, which is responsible for repulsive hydration forces against protein adsorption. 148, 149
Other hydrophilic polymers also generate steric repulsion plus hydration based on similar
mechanisms to PEG. Zwitterionic-based and mixed charge surfaces are believed to introduce a
dense hydration layer via water binding around close packed ionic groups. 143, 144, 1o, m In
addition to these hypotheses, surfaces with molecular-scale heterogeneities on a length-scale
relevant to the fouling protein have also been shown to interfere with adsorption. 131, 132, 152-154 it
is believed that a set of residues on the surface of a protein forms the initial contact with the
surface; once this initial contact is made, cooperative effects from neighboring residues make
additional contact. 154 If a surface can be designed with heterogeneities on the length-scale
relevant to a protein, this initial adsorption event could be disrupted. Mixed SAMs that undergo
curvature-driven phase segregation on metal nanoparticles, resulting in domains as small as
0.5nm, have shown excellent resistance to protein adsorption. 132, 155 Mixed SAMs on flat
surfaces with domain size of tens of nanometers have shown that proteins adsorb preferentially
on the hydrophobic regions; 156 mixed SAMs have also been shown to have superior antifouling
capability compared to either of the respective pure SAMs. 157 The drawback of SAMs is the
need for carefully prepared substrates, the limited types of substrates that can be coated, and their
stability, which can be challenged under long term exposure to water alkalinity or acidity.
In this work, we assembled thin polyelectrolyte multilayer (PEM) films, alternating
deposition of a hydrophobic N-alkylated poly(ethylenimine) and a hydrophilic poly(acrylic) acid,
which we have shown in previous work resulting in highly active microbicidal thin films. 124 We
examine the protein adsorption behavior on these films as a means of determining the primary
mechanism that leads to very low protein adsorption on these systems. Films are constructed
using the layer-by-layer (LbL) deposition technique, " in which multivalent species with
complementary functional groups are adsorbed sequentially onto a substrate. PEM films are
simple and inexpensive to fabricate and can be built on most geometries with molecular scale
control over thickness and surface properties. 31,33 Due to its versatility, LbL technology has
been applied to various applications including drug delivery, 2, 3, 14, 47, 92, 93, 158 membranes and
electrodes for energy applications, 1'7'94 and electro- or magneto-responsive surfaces. 9-11' In
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our previous work, we have demonstrated that the films made with the hydrophobic N-alkylated
poly(ethylenimine) and poly(acrylic) acid showed broad-spectrum contact-killing antimicrobial
activity against both Gram positive and Gram negative bacteria; films were effective in
preventing bacterial colonization from turbid bacteria solution for at least two weeks, while also
preventing adsorption of at least certain types of protein. 14'1" Here, we extend the investigation
of the antimicrobial film to include its potential as an antifouling surface coating. This film
architecture will impart the surface of the implant with contact killing antimicrobial and
antifouling properties.
4.2 Materials and Methods
4.2.1 Materials
Poly(2-ethyl-2-oxazoline) (M. = 50 kDa or 500 kDa), 1-bromododecane, iodomethane,
1-bromooctadecane, 1-bromohexane, 1-bromobutane, tert-amyl alcohol, 3 M sodium acetate
buffer (NaOAc; pH 5.2), as well as solvents and common buffers, were from Sigma-Aldrich (St.
Louis, MO). Poly(2-ethyl-2-oxazoline) (M, = 5kDa), PAA (M. = 5kDa, 50 kDa, and 225 kDa)
and linear poly(ethylenimine) (LPEI; Mn= 25 kDa) were from Polysciences (Warrington, PA).
Phosphate-buffered saline (PBS; pH 7.4, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4) is from
Mediatech, Inc. (Herndon, VA). Silicon wafers (test grade n-type) were from Silicon Quest
(Santa Clara, CA). Quartz crystals (5-MHz frequency) with gold electrodes were from
Tangidyne Corp. (Greenville, SC). Q-Sense quartz crystal sensors, QSX 303 were from Biolin
Scientific Inc. (Lithicum Heights, MD). Glass substrates used to build films on and standard
particles for flat surface cell zeta measurement were from Beckman Coulter Inc. (Brea, CA).
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Cation-adjusted Mueller Hinton Broth II (CMHB) and BactoAgar were from Difco BD (Franklin
Lakes, NJ). Bovine plasma (IBV-N) was purchased from Innovative Research (Novi, MI). All
reagents were used without further purification.
4.2.2 Synthesis of Polymers
Linear N,N-dodecyl,methyl poly(ethylenimine) (DMLPEI; structure shown in Figure 1)
was synthesized as previously described. 7 13 In short, LPEI (M. of 2.2kDa, 21.7kDa or
217 kDa) was produced in house by deacylation of 5kDa, 5OkDa, or 500 kDa poly(2-ethyl-2-
oxazoline); " the product was dissolved in water, precipitated with aqueous KOH, filtered, and
washed repeatedly with water. Complete deacylation was confirmed by NMR. The resulting
deprotonated LPEI was alkylated first with 1 -bromododecane (96 h at 95 C) and then with
iodomethane (24 h at 60 *C) to produce DMLPEI. Syntheses of linear NN-octadecyl-methyl-PEI
(OMLPEI), NN-hexyl-methyl-PEI (HMLPEI) and linear NN-butyl-methyl-PEI (BMLPEI) were
similar, except that LPEI was alkylated with 1 -bromohexane (24 h at 95 *C) and 1 -bromobutane
(24 h at 95 *C), respectively. As for NN-dimethyl-PEI (MMLPEI), LPEI was alkylated by
addition of iodomethane for 24 h at 60 *C.
4.2.3 Preparation of Polyelectrolyte Solutions for Film Deposition
Solutions of PAA were prepared at 2 mg/mL in 0.1 M NaOAc, and were adjusted to pH
3.0, 5.0, and 7.0 with 1 M HCl or 1 M NaOH. Dipping solution of DMLPEI (in 1-butanol),
HMLPEI (in 1-propanol), BMLPEI (in 1-propanol), OMLPEI (in 1-butanol), and MMLPEI (in
deionized water) were prepared at 1 mg/mL. LPEI dipping solution was prepared at 2 mg/mL in
water and adjusted to pH 4.25, with 1 M NaOH and 1 M HCl. All solutions were prepared with
water from a Milli-Q Plus (Bedford, MA) at 18.2 Mg.
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4.2.4 LbL Films Assembly
As previously described, 12 LbL films were assembled on silicon substrates using a
programmable Carl Zeiss HMS slide stainer. Substrates were cleaned with methanol and ultra
pure water, dried under N2, and plasma-etched in 02 using a Harrick PDC-32 G plasma cleaner
on high radiofrequency for 1 min, and then immediately immersed into the first polycation
solution (i.e., DMLPEI, HMLPEI, LPEI, etc.) for at least 10 min. LbL films with the bilayer
architecture of (Polycation/Polyanion). were built, where n is the number of bilayers, the
polycation could be any of the ones mentioned above, and the polyanion was polyacrylic acid
(PAA) in most cases. A bilayer would include a deposition of a layer of the polycation, followed
by a layer of the polyanion; a cascade rinse cycle of three organic solvent rinse baths (1 min, 30
s, 30 s), followed by three water baths (1 min, 30 s, 30 s) was used after deposition of the
polycation, and the reverse cycle of rinse water then organic solvent after PAA dipping. Films
for surface zeta potential measurements were built using the same protocol except that they were
built on glass substrates instead of silicon substrates.
4.2.5 Film Characterization
After film deposition, all films were allowed to air dry. For film growth, thicknesses of
the films were measured using a spectroscopic ellipsometer (Woollam M-2000D). All thickness
measurements were made at five different points on each film and averaged over three separate
films. Roughness measurements of films were generated using a surface profilometer (KLA
Tencor P-16). Thickness measurements of films were also verified using the surface
profilometer. The surface roughness and composition heterogeneity of the films were measured
via tapping mode atomic force microscopy (AFM) in ambient conditions using a Multimode
AFM with an E scanner (Veeco, Santa Barbara) and a SuperSharpSilicon AFM probe tip (SSS-
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NCHR, NanoSensors, Neuchatel, Switzerland). Scanning electron micrographs (SEMs) were
obtained using a JEOL KSM-6700F at 250,000x magnification.
The advancing and receding contact angles of films were measured using the "add and
remove volume" method with a rame-hart model 590 goniometer. This method required the
addition of the drop volume (- 5 IL) slowly to the maximum volume permitted without
increasing the three-phase line; this resulting contact angle is the advancing angle. Volume is
then removed from the maximized drop volume without reducing the three-phase line. The
resultant angle is the receding angle. The contact angle hysteresis is calculated by subtracting
the receding angle from the advancing angle. Hysteresis characterizes the surface topology of
the film, which can help in understanding surface heterogeneity.
Surface zeta potential of glass substrate coated with film was determined using the
Beckman Coulter DelsaNano C instrument with a flat surface cell. The cell constant of an
uncoated glass was determined in 10 mM NaCl. The stock standard monitor particles were also
diluted 100 times in 10 mM NaCl. The sample coated glass substrate is then placed in the flat
surface cell and standard monitor particles were injected into the cell, and surface zeta
measurement was performed. Measurements were taken in triplicate on three different samples.
In order to simulate interactions between the charged proteins and the films, adhesion
interactions were measured between either the (DMLPEI/PAA)9, or (DMLPEI/PAA)O film, and
the AFM cantilever end-attached with spherical Si0 2 glass colloids coated with 2 nm Cr and 50
nm Au (end radius R ~ 300 nm, nominal spring constant k ~ 0.06 N/m, Novascan, Ames, IA). In
order to test the effects of charge on the tip-film interaction, these colloidal tips were
functionalized with either carboxyl- or amine-ended self-assembled monolayers (SAMs) by 24 h
incubation in 3 mM ethanol solutions of 1 1-mercaptoundecanic acid (HS(CH2)1OCOOH, Sigma-
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Aldrich) and 2-aminoethanethiol hydrochloride (HS(CH 2)NH2'HCl, Sigma-Aldrich),
respectively. Colloidal force spectroscopy was then performed by enabling the approach of the
functionalized AFM tips onto the films up to approximately 40 nN maximum compression force
at a constant AFM piezo displacement rate of 1 pm/s in PBS, using a 3D Molecular Force Probe
(MFP-3D, Asylum Research, Santa Barbara, CA). The tips were then held at the constant
position for a pre-defined surface dwell time t before retracting from the film surface at the same
AFM piezo displacement rate of 1 pm/s. The maximum adhesion force was then measured from
each of the retraction force-distance curves. For each pair of interactions between the film and
the functionalized AFM tip, the measurement was repeated for at least n > 25 different locations,
and adhesion forces corresponding to different surface dwell times t were investigated at the
same location for t = 0 - 30 sec.
4.2.6 Quantification of Blood Plasma Adsorption using Quartz Crystal Microbalance (QCM)
A Masscal G1 (quartz crystal microbalance) was used for quantification of protein
adsorption onto surface of the film relative to an uncoated crystal. Film was deposited onto 1-
inch quartz crystals (5-MHz frequency) with gold electrodes (Tangidyne Corp., SC). The
frequency of the blank crystal was recorded before film deposition; frequency of the film-coated
crystal was recorded again after film deposition (dried with N2). Both blank and film-coated
crystals were then incubated in bovine blood plasma (density of approximately 1,025 mg/mL) at
37 'C for 1 h; the crystals were then rinse thrice in fresh PBS then dried with N2. The frequency
of the crystals was recorded again after protein adsorption. Upon protein adsorption, the
oscillatory motion of the crystal declined, and the decreased resonant frequency was measured.
The Sauerbrey equation was used to relate the change in frequency to mass adsorbed per unit
area (C = 17.7 ng cm 2 Hz- for 5-MHz crystals, n = overtone number). 126
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Although the Sauerbrey relation (for rigid layer) is not strictly true for adsorption of
protein due to viscoelastic property of the protein adlayer, it can be used as an approximation to
compare relative amounts of protein adsorbed between the blank and film-coated crystals. In-
situ protein adsorption experiment was done with SiO 2-coated quartz crystal using the Q-Sense
E4 system (Biolin Scientific Inc., Lithicum Heights, MD). Frequency changes are directly
proportional to mass changes according to the Sauerbrey equation as discussed above. In-situ
experiments allow us to monitor the time needed for protein adsorption to come to equilibrium.
The experiments were done in triplicate.
4.3 Results and Discussion
4.3.1 Design of Antifouling Films
Some of the films investigated in this study have previously been shown to resist
adsorption of certain types of protein, while also preventing bacterial colonization from highly
turbid bacteria solution for a period of at least 2 weeks. 15 In this work, we extend the study of
the films to their ability to resist protein adsorption from bovine blood plasma systematically; we
quantitatively examined this phenomenon as a function of the number of bilayers of the film,
hydrophobicity of the polycation and polyanion, assembly condition (i.e., pH of solution) of
films, net surface charge, and molecular weights of both polycation and polyanion to better
understand possible mechanisms of protein resistance.
The charged multilayer film components are shown in Figure 1; the polycations used to
build the LbL films in this study (Figure 4-1A) varied in hydrophobicity with the length of their
N-alkyl chain (ranging from n = 1 to n = 18); throughout this paper, linear NN-dodecyl, methyl
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poly(ethylenimine) is abbreviated as DMLPEI, linear NN-octadecyl, methyl PEI as ODMLPEI,
linear N,N-hexyl, methyl PEI as HMLPEI, linear NN-butyl, methyl PEI as BMLPEI, and linear
N,N-dimethyl PEI as MMLPEI. The polyanion used is poly(acrylic acid) (PAA) (Figure 4-1B).
The bilayer growth of the (DMLPEI/PAA). films had previously been reported; 124 the films
exhibited an initial patchy growth followed by a linear growth. For example, the thickness and
roughness of a (DMLPEI/PAA)I0 is 25 t 3 and 6 ± 3 nm respectively.
A B
H3C CnH 2n+1  COOH
n = 1, 4,6,12, and 18
Figure 4-1: A) Structure of polycation with various N-alkyl chain lengths; B) Structure of poly
(acrylic acid) (PAA).
4.3.2 Antifouling Activity of Films
We first investigated the antifouling behavior of the (DMLPEI/PAA), films with
increasing number of bilayers, for cases in which the hydrophobic DMLPEI or the hydrophilic
PAA is the topmost layer (Figure 4-2). We observed that the protein resistance of the films
improved with an increasing number of bilayers relative to an uncoated substrate, with best
performance beyond 5.0 bilayers; below 5.0 bilayers, the film was in a patchy growth regime,
during which the polyion layer does not fully coat the substrate, leaving uncovered regions on
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the surface.124 Once the surface was completely coated with film, we saw a significant drop in
the mass of protein adsorbed on the surface compared to a silicon control.
Number of Bilayers
B
100
80
60
40
20
0
Cov
41, Number of Bilayers
Figure 4-2: Protein adsorption onto surfaces of (DMLPEI/PAA), with increasing number of
bilayers; A) Odd number of bilayers represents having DMLPEI as the topmost layer; B) Even
number of bilayers represents having PAA as the topmost layer.
Overall, we observed significantly less protein adsorbed onto the surfaces of film for
which PAA was the topmost layer (Figure 4-2B); 5 ± 2 ng / cm 2 on the 10 bilayers film versus 30
- 6 ng / cm 2 on the 9.5 bilayers film. Surfaces that adsorb less than 5 ng / cm 2 of protein are
considered ultra-low fouling surfaces. 142 The uncoated substrate adsorbed 90 ± 14 ng / cm2 of
protein onto its surface.
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Contact angle measurements of the 9.5 bilayers and 10.0 bilayer films indicate contact
angles of 960 ± 50 and 850 ± 30 respectively, showing that the films with PAA as the topmost
layer are more hydrophilic (Table 4-1). This may be anticipated given that PAA is a highly
hydrophilic polymer, and the N-alkylated PEI polymers are hydrophobic; however, it is clear that
the chains for both surfaces are highly interpenetrated, leading to contact angles that fall between
the two extremes of the neat polymers, and yielding only a small difference between the
DMLPEI and PAA topped surfaces. LbL films in general have shown to be highly
interpenetrated; instead of forming well-stratified layers, the layers interdigitate, as has been
shown for several different polyelectrolyte systems. 36,39,159 In some multilayer systems, the
interpenetration is extensive enough that the topmost layer will present segments at the surface
from the underlying polyion. The topmost layer in the case of these LbL films would be
expected to present a mixture of the hydrophobic DMLPEI and hydrophilic PAA segments.
In addition, surface zeta potential measurements of the two films showed that the PAA-
topped films had a surface charge of -2 ± 2 mV (near neutral), while the DMLPEI-topped film
exhibited a surface charge of 40 ± 5 mV (Table 4-1). It is clear from the near-zero surface
potential that the PAA-topped films, which exhibit a highly effective protein resistant surface,
likely display a mixed-charge surface in which positively and negatively charged groups are
equally present. Such LbL films that exhibit a non-reversal of charge with alternating
adsorption, have been presented recently in the literature, and indicate that other secondary
interactions play a role in film build-up. 160,161 When only the hydrophobic polycation DMLPEI
was directly spincoated onto a substrate, we saw approximately 40 times more protein adsorption
(220 ± 28 ng / cm2) on the surface relative to the (DMLPEI/PAA) 0 film (Table 4-1). With these
observations, we hypothesized that the architecture of the (DMLPEI/PAA)IO film built with the
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highly hydrophobic DMLPEI and hydrophilic PAA may present molecular to nanoscale surface
heterogeneities making it unfavorable for protein to adsorb onto its surface; furthermore, a
meaningful role appears also to be due to the presence of a charge neutral surface, minimizing
favorable net electrostatic attractions between the film surface and protein.
Table 4-1 Summary of mass of protein adsorbed, surface charge, and contact angle on uncoated
and film-coated substrate
Adsorbed Protein Surface Charge Contact Angle
(ng / cm2 ) (mV) (0)
Uncoated Control 90 14 -12 3 0
Spincoated DMLPEI 220 28 55 6 105 6
(DMLPEI/PAA) 9.5  30 6 40 5 96 5
(DMLPEI/PAA)10  5 2 -2 2 85 3
We then examined the dependence of the antifouling activity on the assembly conditions
of the film, specifically the change in the pH of the PAA solution; because the hydrophobic
polycation DMLPEI was dissolved in 1-butanol, pH of its solution is not changed. As seen in
Figure 4-3A, we found no dependence of antifouling activity with changes in pH of the PAA
solution during film assembly; films built at the three different pHs of PAA were all effective in
retarding protein adsorption. Surface zeta potential measurements of all the films showed near
neutral surface charge (Figure 4-3B), while contact angle measurements showed no statistically
significant difference in the average angle measured on the surface of all three films: advancing
angle = 83* ± 3*, receding angle = 24* ± 40, hysteresis = 590 ± 20. Early conclusion from this
observation is that while PAA is necessary in the fabrication of the film, it alone may not be the
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key player in imparting the films with antifouling activity. As mentioned before, the polycation
DMLPEI itself coated on a surface does not have any antifouling property; so PAA adsorption is
necessary to create a surface that is heterogeneous with hydrophobic / hydrophilic regions, as
well as to produce charge neutrality on the surface. We have shown previously that PAA
assembled into films at different pH resulted in films with highly different antimicrobial activity
due to the need to present the DMLPEI chain segments as denser, less ionically bound positively
charged groups on the surface; 124 however in the case of designing films for antifouling activity,
the controlling factor may have more to do with surface heterogeneity than polyelectrolyte chain
segment density. The highly hydrophobic DMLPEI and hydrophilic PAA, regardless of their
surface charge densities, could still present molecular to nanoscale surface heterogeneities
unfavorable for protein adsorption.
A B
6 I
0C 4 -
pH3 pH5 pH7 pH3 pH5 pH7
pH of PAA Solution pH of PAA Solution
Figure 4-3: A) Protein adsorption onto surfaces of (DMLPEI/PAA)10 films built with PAA at pH 3,
5, and 7; B) Surface zeta potential of (DMLPEI/PAA)10 films built with PAA at pH 3, 5, and 7.
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To further investigate the key elements that impart the film with antifouling property, we
decided to alter the hydrophobicity of the polycation by varying the N-alkyl chain length (n = 1
to n = 18) (Figure 4-4A), while maintaining PAA as the polyanion; hydrophobicity increases
with alkyl chain length. Figure 4-4A shows the mass of protein adsorbed onto these films with
increasing hydrophobicity of the polycation. Films were also made with linear poly
(ethylenimine) (LPEI), the unmodified backbone polymer of the N-alkylated polycation. The
antifouling activity of the films improved with increasing hydrophobicity of the polycation, until
n = 12 and beyond, where the mass of protein adsorbed reached a minimum. This suggests that a
certain level of hydrophobicity coupled with the hydrophilicity of PAA is needed to impart the
film with optimal antifouling property, presumably creating a heterogeneous surface made up of
polymer segments from both the hydrophobic polycation and hydrophilic PAA. Films made
with either the hydrophilic LPEI or MMLPEI (n = 1) showed levels of protein adsorption
comparable to an uncoated control.
Films also showed increasing contact angle with increasing hydrophobicity of the
polycation (Figure 4-4B); more importantly, the hysteresis of the films increased with increasing
hydrophobicity of the polycation, showing an increase in surface heterogeneity. Contact angle
hysteresis is a macroscopic indication of the presence of regions with contrasting surface
properties that could potentially be the hydrophobic and hydrophilic domains suggested
previously that resist protein adsorption. Surface zeta potential measurement, as shown in Figure
4-4C increases from - 35 ± 7 mV for the (LPEI/PAA)IO film to neutral for the
(ODMLPEI/PAA) 0 film. Interestingly, when we measured the surface charge of the 9.5 bilayers
film, the surface remained positively charged (approximately + 40 mV) regardless of the level of
hydrophobicity of the polycation (Figure 4-4C). This set of data indicates that at low
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hydrophobicity (i.e., LPEI and MMLPEI films), the films behave similarly to classic LbL film,
where complete charge reversal happens after each dipping cycle; 3, 162 but, with increasing
hydrophobicity, the polycation starts to play a more prominent role in the film buildup. After
each polycation-dipping step, the polycation adsorbs giving a positive surface charge; but when
PAA adsorbs, PAA only adsorbs enough to neutralize the surface charge without reversing it.
Given the hydrophobic nature of the film surface, we hypothesize that the driving force for the
adsorption of the hydrophilic PAA chain could be reduced as the underlying surface becomes
more hydrophobic. Also, because these films are highly interpenetrated, the film surface
presents segments of both polymers; so, when the next hydrophobic polycation layer adsorbs, the
polycation adsorbs via hydrophobic interactions with some polycation segments already present
on the film surface, thus driving adsorption until the surface achieves a net positive charge again;
161 this process repeats itself with each dipping cycle. In principal, during LbL film assembly,
charge reversal happens after every polyelectrolyte-dipping step; in our case, charge reversal
doesn't occur after the PAA dipping step. Film deposition onto a surface without charge reversal
has been previously reported. 160, 163, 164 This shows that interactions other than electrostatic
contribute to the formation of multilayer films; under ordinary circumstances, self-attraction of
the polyion backbone will generally lead to charge reversal rather than just simple charge
compensation. 161 When these attractive forces are decreased for the polyanion, it serves to
neutralize the surface sufficiently for deposition of the next polycation layer. These findings also
suggest that the reason why the PAA-topped film is more effective in preventing adsorption of
protein, is likely due to its surface being made up of highly interpenetrated segments of both
hydrophobic and hydrophilic polymers; just enough PAA is adsorbed to neutralize the surface
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charge minimizing protein adsorption via electrostatic attractions, while also presenting a
heterogeneous surface consisting of hydrophilic / hydrophobic nanostructures. 131,132
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Figure 4-4: A) Mass of protein adsorbed, and B) contact angle measurement of 10 bilayers
(LPEI/PAA)10 as well as (XMLPEI/PAA)10 films made with polycation that varies in their N-alkyl
chain length (n = 1 to n = 18) ; C) surface zeta potential of 9.5 and 10 bilayers (LPEI/PAA), and
(XMLPEI/PAA). films.
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Next we varied the molecular weight of the polycation DMLPEI used to assemble the
films again maintaining PAA (MW = 50kDa) at the polyanion; films up to this point were made
with 217kDa DMLPEI (Figure 4-5A). When films were assembled with 21.7kDa DMLPEI, the
film showed an increase in the mass of protein adsorbed (14 t 4 ng / cm 2) relative to the film
made with the 217kDa DMLPEI (5 ±2 ng / cm 2). Film that was built with the 2.2kDa DMLPEI
had similar protein adsorption behavior as an uncoated substrate. Contact angle measurements
of the films showed an increase in the advancing contact angle and hysteresis with increasing
molecular weight of DMLPEI used (Figure 4-5B). Surface zeta potential measurement of the
PAA-topped (DMLPEI/PAA)io films showed an increase from - 31 ± 5 mV for the 2.2kDa
DMLPEI film to - 2 ±2 mV for the 217kDa DMLPEI film (Figure 4-5C), showing charge
reversal on the surface with the lower molecular weight DMLPEI, and not at higher molecular
weight DMLPEI. More interestingly, when we measured the surface zeta potential of the
DMLPEI-topped (DMLPEI/PAA) 9.5 films, we saw the opposite trend; the surface charge of the
films made with the lower molecular weight DMLPEIs (i.e., 2.2 kDa and 21.7 kDa) were barely
positively charged (Figure 4-5C), in contrary as well to previous data showing that polycation-
topped films made with 217kDa N-alkylated polycation were always highly positively charged
(Figure 4-4C). We hypothesized that since the molecular weight of the PAA used was 50 kDa,
the smaller molecular weight of the DMLPEI (i.e., 2.2 kDa and 21.7 kDa) when adsorbed onto
the PAA-topped surface, they adsorbed only to the point of neutralizing the surface charge.
Charge overcompensation does not happen because each of the polymeric chain for the lower
molecular weight DMLPEIs is much shorter than the 217kDa DMLPEI; the number of sites for
hydrophobic interaction to occur to reverse the surface charge to positive is much smaller.
116
-F
B
601
40*
20
'1~
'V
MW of Polycation DMLPEI MW of Polycation DMLPEI
C
S 40- 0 9.5 bilayers
E A 10.0 bilayers
40
02
U-40
MW of Polycation DMLPEI
Figure 4-5: A) Mass of protein adsorbed, B) contact angle measurements, C) surface zeta potential
of 9.5 and 10.0 bilayers (DMLPEI/PAA). films built with DMLPEI of various molecular weight
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117
A
80E
0
CmS 60
40
0 
20
C-" Advancing
. M Receding
Hysteresis
-
-
-
Interestingly, when we examined the influence of molecular weight of PAA to the anti-
fouling activity of the film, we saw no dependence on the molecular weight of PAA used during
film assembly (Figure 4-6A). Films thus far were built with 50kDa PAA; when films were built
with PAA with molecular weight of either 5kDa or 225kDa, we saw similar anti-fouling
capability. Contact angle and surface zeta measurements showed statistically insignificant
difference among the films (Figure 4-6B and Figure 4-6C). This finding shows that PAA is
necessary in build up of the film but the key player in determining the anti-fouling capability of
the film is the hydrophobic polycation; but without PAA, the hydrophobic polycation itself does
not have the ability to resist protein adsorption.
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Figure 4-6: A) Mass of protein adsorbed, B) contact angle, C) surface zeta measurement on
(DMLPEI/PAA) 0 films built with PAA with different molecular weight.
All protein adsorption experiments reported thus far were done with undiluted bovine
plasma. In order to determine if the charge of protein plays an important role in adsorption
behavior, we conducted experiments with either a positively charged protein (i.e. lysozyme) or
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negatively charged protein (i.e. pepsin). Results showed that there is no statistically significant
difference in protein adsorption behavior on the film regardless of the charge of the protein
(Figure 4-7). Consistent with previously obtained data with plasma, the DMLPEI-topped film
adsorbed much more protein than the PAA-topped film regardless of the charge of the protein.
This result shows that while electrostatic interaction may be one of the factors contributing to the
adsorption of protein, it is not the major one in determining the amount of protein adsorbed on
the surface of our film; in fact, this set of data implies that the larger tendency of the DMLPEI-
topped film to adsorb protein is due in large part to the more hydrophobic nature of the surface.
Having the hydrophobic DMLPEI as the final adsorbed layer of polymer creates a surface that
consists primarily of the hydrophobic polymer segments; positive surface zeta potential after
DMLPEI adsorption shows that enough polycation adsorbs to reverse the surface charge,
whereas during the PAA dipping step, only enough PAA adsorbed to neutralize the surface. The
PAA-topped film exhibits superior antifouling activity because of its relatively hydrophilic
nature when compared to the DMLPEI-topped film, and more importantly, because PAA adsorbs
just enough to neutralize the surface charge, the PAA-topped film surface is rich in both the
hydrophobic and hydrophilic polymer segments, potentially creating a more heterogeneous
surface than a DMLPEI-topped surface, with nanoscale segregation on a length-scale relevant for
preventing protein adsorption.
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Figure 4-7: Protein adsorption experiment on (DMLPEIPAA)lo and (DMLPEI/PAA) 9.5 films With
plasma, lysozyme or pepsin.
In order to simulate the interactions between either a negatively or positively charged
protein with our (DMLPEIIPAA)n film surface, a carboxyl - functionalized atomic force
microscopy (AFM) tip or a amine - functionalized AFM tip, respectively was used to perform a
set of adhesion tests. In these adhesion experiments, increasing surface dwell time, t,
significantly increased the maximum adhesion forces, F,,h,,,,frbt imvabt h
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carboxyl - and amine - functionalized tips (Figure 4-8). This increase in Fahesi, with t was
because a longer surface dwell time would allow a larger degree of interactions between the
molecules in contact to take place, such as van der Waals, electrostatic and hydrophobic
interactions. More importantly, Fadhesionl was significantly smaller on the 10 bilayers film than
those on the 9.5 bilayers film for both types of tips; however, Fahesionl was significantly larger for
both films with the amine - functionalized tips, than the carboxyl - functionalized tips (two-way
analysis of variance, p <0.01). At the conditions for the experiments were performed (pH 7.4 of
PBS), the amine groups on the amine - functionalized tips may not be fully protonated, thus
decreasing the overall positive charge of the tip, as compared to the carboxyl groups on the
carboxyl - functionalized tip, which would be completely deprotonated (i.e. highly negatively
charged); thus this difference is not likely due to a higher charge on the amine functional tips.
Since the adhesion was consistently lower on the 10 bilayers film with both negatively and
positively charged tips, the adhesion studies suggested that surface interactions were mainly
governed by the hydrophobicity, rather than the nature of the charge on the tips and the films.
This independent AFM study is in strong agreement with our other experimental data showing
that the more hydrophobic and charged surface (e.g., 9.5 bilayers film) preferentially adsorbed
more protein via hydrophobic and/or electrostatic interactions with complementary domains on
the surface of a protein molecule, while the neutral surfaces (e.g., 10 bilayers film) are very
effective in preventing protein adsorption. 139''41,165 The surface of the 10 bilayers film could be
more heterogeneous with hydrophobic / hydrophilic regions presenting dimensional restrictions
for protein to adsorb.
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Figure 4-8: AFM adhesion tests with A) COOH-functionalized nano-colloidal tip, and B) NH 2-
functionalized nano-colloidal tip on surfaces of (DMLPEI/PAA)9 .5 and (DMLPEI/PAA) 0 films.
Both sets of data show stronger adhesion on the DMLPEI-topped (DMLPEI/PAA)9 .5 film, with
overall stronger adhesion with the NH 2- functionalized tip.
While charge neutrality and hydrophilicity could help with protein retardation via the
recently proposed mixed charge hydration repulsion mechanism, the PAA topped films are still
relatively hydrophobic. The AFM adhesion studies also suggest that the zwitterionic/mixed-
charge hydration repulsion hypothesis does not apply to our system; during the adhesion
experiments, no long range repulsion forces due to the existence of a strong hydration layer was
observed (Figure 4-9), as observed in the case for PEG or zwitterionic/mixed-charge materials
(Figure 4-10). 145,150,151,166 As previously stated (Table 4-1), the contact angle of the films were
approximately 800 for the 10 bilayers film, and 90* for the 9.5 bilayers film, which are contact
angles much larger than reported for zwitterionic surfaces (< 20*). "5 In fact, the contact angles
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reported on our films are in agreement with the contact angles reported on surfaces that resist
protein adsorption because of the existence of nanoscale hydrophobic / hydrophilic domains. "
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Figure 4-9: Typical approach force curves on 10- and 9.5- bilayers (DMLPEI/PAA), films with
either COOH- or NH 2- functionalized AFM tip; A) and B) are with COOH - functionalized tips; C)
and D) are with NH 2 - functionalized tips.
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Figure 4-10: Force curves showing repulsion from PEO SAM surfaces, and adhesion on CH 3 SAM
surfaces with a HAS (albumin) modified tip; adapted from Rixman et. al. 1"
Shown in Figure 4-11 are scanning electron micrographs (SEMs) of the surfaces of the
9.5 and 10 bilayers (DMLPEI/PAA)n films, to show the possible existence of nanoscale domains
on the surface of our films. The surface of the 10 bilayers film indeed shows domains (- 10 -20
nm) that are within the length scale that would prevent stable adsorption of proteins.
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Figure 4-11: SEM images of 10-bilayers (left) and 9.5-bilayers (right) (DMLPEI/PAA). films
showing existence of nanoscale domains on the surface of the films.
In addition, tapping mode AFM images of the (DMLPEI/PAA)IO and (DMLPEI/PAA)9,
films (Figure 4-12) showed that the PAA-topped (DMLPEI/PAA) 0 film was more rough than
the DMLPEI-topped (DMLPEI/PAA)9 5 film: Rq = 9.6 ± 1.6 nm versus Rq = 2.0 ± 0.2 nm
respectively. The DMLPEI-topped film showed more of a flat layer of the polycation on the
surface and less interpenetration of the two polymers (Figure 4-12B), in agreement with the
highly positive surface charge of the 9.5-bilayer film (Table 4-1). The phase AFM (Figure
4-12, center top) of the 10-bilayer film shows some phase shift contrast suggesting a smaller-
scale segregation; indeed higher-resolution SEM of the film (Figure 4-11, left) shows smaller
domain sizes. These AFMs and SEMs suggest some nanoscale segregation of
hydrophobic/hydrophilic domains on the (DMLPEI/PAA)0 film surface, thereby preventing
protein from adsorbing onto the surface, in agreement with previously reported results."' 1"55
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Figure 4-12: Atomic force micrographs of A. (DMLPEI/PAA)10 and B. (DMLPEI/PAA)9 .5 films;
scale bar = 50 nm. From left to right is height (color bar = 50 nm), phase (color bar = 500) and
amplitude (color bar = 0.2 V) image respectively.
4.4 Conclusions
The ability of the LbL films investigated herein to resist protein adsorption (and
previously reported long-term biofilm formation) suggests their potential use as antifouling
coatings for applications ranging from water purification membranes to biomedical implants.
We demonstrate that the surface topology of the films could be engineered by carefully choosing
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their components and that a fine hydrophobicity/hydrophilicity balance on the surface of the
films is needed to create molecular-level heterogeneities unfavorable to protein adsorption. We
hypothesize that due to the contrasting nature of the polyelectrolytes making up the films,
nanoscale segregation of the polymer segments into hydrophobic and hydrophilic moieties
occurs on the surface, thus creating an unfavorable environment for protein adsorption.
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Chapter 5: Mechanistic Study of Microbicidal Films
Part of the results discussed within this chapter is adapted from "On Structural Damage
Incurred by Bacteria Upon Exposure to Hydrophobic Polycationic Coatings" by Hsu, B. B.,
Ouyang, J., Wong, S. Y., Hammond, P. T., Klibanov, A. M. Biotechnol Lett 33 (2), 411-416,
2011. 10.1007/s10529-010-0419-1, @ 2011 SpringerLink, and "Mechanism of Inactivation of
Influenza Viruses by Immobilized Hydrophobic Polycations" by Hsu, B. B., Wong, S. Y.,
Hammond, P. T., Chen, J. Z., Klibanov, A. M. P Natl Acad Sci USA 108 (1), 61-66, 2011.
10.1073/pnas.1017012108, @ 2011 P Natl Acad Sci
5.1 Introduction
We have successfully designed a set of contact-killing ionically cross-linked polymeric
thin films using the LbL technology. 124 A polycation, linear NN-dodecyl,methyl-
polyethylenimine (DMLPEI), with microbicidal activity was layered with a polyanion, such as
poly(acrylic acid), to create LbL films highly effective against Escherichia coli and
Staphylococcus aureus (Gram negative and positive bacteria, respectively), as well as influenza
AIWSN (H1N1) virus. The dependence of the microbicidal activity on the pH during and post-
assembly of LbL film formation, the nature of the polycation and polyanion, the number of
layers in the LbL film, and other experimental variables were investigated quantitatively. We
demonstrated that microbicidal functionality could be imparted onto surfaces using LbL
technology by using the right combination of polycations and polyanions, as well as assembly
and/or post-assembly conditions. LbL films as thin as 10 nm, from the series of
(DMLPEI/PAA)n films built with PAA at pH 3 were 100% lethal to both airborne and
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waterborne Gram positive and Gram negative bacteria, as well as to a strain of influenza virus.
We have also demonstrated that degradable drug releasing films were able to grow on top of the
microbicidal film, creating a multifunctional film construct offering permanent microbicidal
functionality and controlled drug release. Our films were effective in preventing bacterial
attachment to surfaces for at least two weeks, and thus indicate promising properties for
prevention of biofilms on surfaces. While highly microbicidal, the LbL coatings were also found
to be non-cytotoxic to a couple of mammalian cell lines (i.e., pre-osteoblasts and epithelial cells)
based on cell viability assays.
Next, we would like to understand the mechanism by which the LbL coatings inactivate
microbes (bacteria and virus), particularly using surface characterization methods (i.e.,
visualization of microbes with scanning electron microscopy (SEM), and surface chemistry
characterization with grazing angle FT-IR). More importantly, we would like to confirm that the
formation of LbL film does not alter the mechanism in which the microbicidal polycation
inactivates microbes.
5.2 Materials and Methods
5.2.1 Polymer Synthesis
Poly(2-ethyl-2-oxazoline) (Mw of 500 kDa), 1-bromododecane, iodomethane, tert-amyl
alcohol, and other chemicals and solvents were from Sigma-Aldrich. Linear N,N-dodecyl-
methyl-PEI (DMLPEI) was synthesized as previously described. " In short, linear PEI (LPEI)
(Mw of 217 kDa) was produced by deacylation of poly(2-ethyl-2-oxazoline); " the resultant LPEI
was dissolved in water, precipitated with aqueous KOH, filtered, and washed repeatedly with
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water. The resultant deprotonated LPEI was then alkylated first with 1-bromododecane (96 hr at
95*C) and then with iodomethane (24 hr at 60*C) to produce the end product DMLPEI.
5.2.2 LbL Film Assembly and Preparation of Microbicidal "Paint"
LbL films were assembled on silicon substrates (Silicon Quest International) with a
programmable Carl Zeiss HMS slide stainer, as previously described. 124 Substrates were first
plasma-etched in oxygen using a Harrick PDC-32G plasma cleaner on high RF for 1 min and
then immediately immersed into a solution of a 1 mg/ml of DMLPEI dissolved in 1-butanol for
at least 10 min. The LbL films were built up by alternating the deposition of DMLPEI and poly
(acrylic acid) (PAA); solution of PAA was at a concentration of 2 mg/ml in 0.1 M sodium
acetate buffer, pH 5.1.
Microbicidal "paints" were deposited onto silicon substrates from a 50 mg/ml DMLPEI
solution using a cotton swab; the paint was then left to dry overnight.
5.2.3 Visualization of Bacteria and Virus with Scanning Electron Microscopy (SEM)
The bacterial strains used herein were S. aureus (ATCC, 25923) and E. coli (E.coli
genetic stock center, CGSC4401). The influenza virus strain used was A/WSN/33 (H1N1); the
virus was grown in the Madin-Darby Canine Kidney (MDCK) medium from ATCC. 71 The
protocol to test the samples for bactericidal and virucidal activity was that described previously.
1 Briefly, S. aureus was grown overnight in cation-adjusted Mueller Hinton Broth II (CMHB)
(Difco, BD) and diluted to 5 x 106 cells/ml. The diluted bacterial suspension was sprayed onto
samples (~10 ml/min) using a gas chromatography sprayer (VWR International, cat. No. 21428-
350). The same procedure was used for E. coli except that it was grown overnight in LB-Miller
broth (VWR), diluted to 5 x 107 cells/ml. The sprayed samples, including the bare substrate and
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film-coated substrates (LbL and paint) were incubated at room temperate for 30 min, and then
fixed using a Karnovsky's Fixative kit (Polysciences, Inc.) according to manufacturer's
specifications. In short, samples were incubated in a fixing solution of 2% paraformaldehyde
plus 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4 for 2 h and then rinsed for
10 min in phosphate buffer. Next, the samples were incubated in 1% osmium tetroxide solution
for 1 h away from light, rinsed with phosphate buffer, and serially dehydrated in 25, 50, 70, and
95% (v/v) ethanol solutions for 10 min each, before final dehydration (in 100% ethanol) thrice,
10 min each. Samples were then freeze-dried in liquid N2 and sputter-coated (gold/palladium)
before imaging with a JEOL JSM-6060 SEM at 11,000x magnification.
Uncoated and film-coated substrates were placed in a Petri dish, and 10 pL droplet of the
WSN influenza virus solution was placed in the center before sandwiching with a plain substrate
to spread the virus droplet. The sandwich system was incubated at room temperature for 30 min
before fixing the samples with Karnovsky's fixative kit, as described above. The fixed samples
were then imaged with a JEOL KSM-6700F SEM at 100,000x magnification.
5.2.4 Surface Characterization of Film with Grazing Angle FT-IR (GA TR)
Thicknesses of LbL films were measured using a spectroscopic ellipsometer (Woollam
M-2000D). Grazing angle Fourier transformed infrared (GATR) spectra of (DMLPEI/PAA)so
films with PAA at pH 3.0, 5.0, and 7.0 were acquired using a Nexus 6700 FT-IR (Thermo-
Nicolet); LbL film thickness was fixed to approximately 80 nm by varying the number of
bilayers constructed for each pH of PAA used.
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5.3 Results and Discussion
5.3.1 Mechanism of Killing of Bacteria by Microbicidal LbL Film Compared to Microbicidal
"Paint"
We visualized the bacteria upon exposure to the microbicidal surfaces (LbL and paint);
shown in Figure 5-1 and Figure 5-2 are scanning electron micrographs (SEMs) of S.aureus and
E.coli respectively upon exposure to bare Si surfaces, Si surfaces coated with the microbicidal
LbL film, (DMLPEI/PAA)9.5 with PAA at pH 3.0, or Si surfaces "painted" with DMLPEI.
Both strains of bacteria showed drastic morphological change upon exposure to the LbL or
"painted" film; these SEMs provided direct evidence of disruption of the microbes' membrane
compromising their integrity. The similarity in disruption of the membrane on the LbL versus
the "painted" film shows that the construction of the LbL film does not alter the mechanism of
killing by the microbicidal polymer DMLPEI. These micrographs showed that bacteria exposed
to surface coated with the microbicidal polymer exhibited profound structural deformations, as
opposed to the well-defined and smooth morphology seen for the bacteria on bare substrate. 167
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Figure 5-1: SEM images of S.aureus on A) bare Si substrate, B) LbL film, C) bare Si substrate, and
D) painted film; both types of films show similar morphological damage to bacteria.
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Figure 5-2: SEM images of E.coli on A) bare Si substrate, B) LbL microbicidal film, C) bare Si
substrate, and D) painted film; both types of films show similar structural damages to bacteria.
Additionally, grazing angle FT-IR spectra (Figure 5-3) of the "painted" and LbL films
support this conclusion; the peaks in the spectra show up at the same wave numbers for both
types of films, suggesting that the conformation of the polymeric chains is not perturbed from
the formation of LbL film. The difference in peak intensity between the "painted" and the LbL
film was due to the difference in the amount of material present: "painted" films are micron in
thickness while LbL films are nanometer in thickness.
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Figure 5-3: Grazing angle FT-IR of painted and (DMLPEI/PAA)n films built with PAA at pH 3, 5,
and 7.
The spectra also show that the CH3 peaks are barely visible on all samples, with
decreasing intensity as the pH of PAA increases. In addition, the CH2 symmetric and
asymmetric peaks show up at frequencies between that of a solid crystalline-phase
(CH3(CH2)21SH) and disordered liquid crystalline phase (CH3(CH2)7SH). 16 Data from the CH2
symmetric stretch peak provides information of the local environment of an individual chain; the
data indicates that the average local chain environment appears to be in between of a bulk
crystalline phase and bulk disordered (liquid) phase. The spectra obtained for our samples
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coincide with SAMs of alkanethiols with alkyl chain lengths between n= 7 and n = 11; these
SAMs exhibit higher degree of disordering than that of longer chain assemblies (up to n = 21) as
a result of a combination of conformationally disordered and thermally disordered alkyl chains
because of the presence of gauche kinks and weak interchain interactions, respectively. 16" Also,
the CH2 stretching mode absorption intensity is directly related to the number of CH2 units per
alkyl group; the decrease in the intensity of these peaks with increasing pH of PAA suggests
incorporation of less of the microbicidal polycation per layer, which correlates well with the
bactericidal activity of the films; recall that the films made with PAA at pH 3 showed the highest
level of activity.
Previous mechanistic studies on the microbicidal polycation DMLPEI showed that both
airborne and waterborne bacteria were killed upon contact with surfaces functionalized with this
polymer; in fact, fluorescent live/dead assay showed that the indeed the integrity of the bacterial
membrane was compromised by the hydrophobic polycation. 72, 3 We have confirmed the
structural damage to the membrane of these bacteria with these micrographs. The shrunken
appearance of the bacteria exposed to the microbicidal surfaces indicates a loss of structural
integrity, which is maintained by the cellular wall; this observation suggest interaction between
the bacteria's peptidoglycan layer and the microbicidal polycation. Indeed, study examining the
quantity of intracellular protein leaked, shows considerable fraction of the total cellular protein is
spilled; the quantity and composition of protein exposed is similar to that released using standard
lysozyme/EDTA treatment, suggesting both treatments may target the same components on the
bacterial cell membranes (Table 5-1). 74 Lysozyme/EDTA treatment is known to release the
periplasmic proteins, leaving the cytoplasm relatively intact. 169 Study quantifying the relative
amount of periplasmic versus cytoplasmic enzymes leaked shows a disproportionately small
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fraction of cytoplasmic enzyme released (Table 5-2). It appears that the outer periplasmic
membrane of the bacterium is significantly compromised by the microbicidal polycation, while
the cytoplasmic membrane suffers relatively minor damage.
Table 5-1 The protein concentration released into solution by E.coli and S.aureus after various
treatments 74
Treatment Total protein concentrations (ptg/ml)
E. coli K12 E. coli BAA-196a S. aureus
None 0.23 i 0.03 0.23 i 0.03 0.20 i 0.04
N,N-Dodecyl,methyl-PEI coating 0.63 ± 0.03 0.93 ± 0.01 0.53 ± 0.01
Lysozyme/EDTA 0.56 ± 0.05
French press 15.6 ± 0.6 14.8 ± 0.7 3.2 i 0.3
Each measurement was performed in duplicate,
a The same conditions as with the K12 strain
and the values are given as averages ± standard deviations
Table 5-2 The concentration of periplasmic and cytoplasmic enzymes (#-lactamase and #-
galactosidase, respectively) released into solution by E.coli after various treatments 74
Treatment E. coli enzyme concentrations
(ng/ml)
#-Lactamasea f#-Galactosidasea
None 0.060 i 0.001 1.9 i 0.2
N,N-Dodecyl,methyl-PEI 0.11 + 0.01 9.9 i 0.6
coating
French press 0.68 i 0.04 1700 t 100
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5.3.2 Mechanism of Inactivation of Influenza Virus by Microbicidal LbL Film and
Microbicidal "Paint"
We then extended the mechanistic study to influenza virus; shown in Figure 5-4 are
micrographs of the WSN strain of influenza virus after exposure to either an uncoated substrate
or an LbL-coated substrate. Virus particles on a plain uncoated substrate showed no visible
structural damage. On the contrary, virus particles exposed to the LbL-coated surface, showed a
mixture of either a significantly damaged virus particle (Figure 5-4B) or no visible damage
(similar to appearance of virus particle on plain uncoated substrate, Figure 5-4A). This
observation is in agreement with result reported for virus particles exposed to the microbicidal
"paints" (Figure 5-5). 113 This shows that the formation of LbL film does not alter the way in
which the microbicidal polycation inactivates the influenza virus. Virus particles exposed to
both types of microbicidal surfaces (LbL and paint) demonstrate very similar structural damages.
Figure 5-4: SEM images of WSN influenza virus after exposure to A) uncoated Si wafer, B)
(DMLPEI/PAA) 7.5 film coated Si wafer.
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Mechanistic study by Hsu et al. on the microbicidal-painted surface reported that virus
particles upon exposure to the painted surface irreversibly adhere to it, and then significant
structural damages occur leading to inactivation of the virus particles (Figure 5-6). The study
has also shown that viral RNA is released into solution, while viral proteins remain intact. 13
Figure 5-5: SEM images of the WSN strain of influenza virus after exposure to uncoated (A) and
DMLPEI-painted (B and C) silicon wafers. A larger fraction of viral particles showed substantial
structural damage (B), while a smaller fraction showed no visible damage (C). 113
A Diffusion to surface B Adherence to immobilized C Leakage of RNA and
polycation influenza inactivation ,3
Influenza
Viral RNA
Polycation-coated I -
surface
Figure 5-6: Proposed mechanism of influenza virus inactivation by microbicidal coated surfaces. 113
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5.4 Conclusions
We have shown that incorporation of the microbicidal polycation (e.g., NN - dodecyl,
methyl PEI) into LbL film does not alter the microbicidal functionality and mechanism in which
it inactivates microbes. Both bacteria and viruses membrane were significantly damaged upon
exposure to the microbicidal surface, leading to inactivation.
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Chapter 6: Conclusion and Future Work
6.1 Thesis Summary
In the past decade, layer-by-layer (LbL) assembly has become an important tool for the
design of highly versatile nanomaterials for various applications; more specifically, in the
biomedicine field, this technique has been utilized to create surface coatings with various
functionalities including delivery of drug agents, mediation of cellular behavior, and many more.
The main aim of this thesis work was to use the LbL deposition technique to create a broadly
applicable multifunctional platform film technology that would satisfy various thin films medical
implant coating applications; this film would impart a surface with long-term antimicrobial /
antifouling functionality via a permanent microbicidal base coating, and controlled delivery of
therapeutic agents of interest via a degradable multilayer top film. Efforts were focused on
maximizing and understanding the factors that influence the microbicidal / antifouling
functionality of the polyelectrolyte multilayer (PEM) film; the N-alkylated microbicidal
polycations previously developed in the Klibanov group at MIT were incorporated into the PEM
film via LbL assembly. 71 Hydrolytically degradable multilayer top films previously developed
in the Hammond group 2, were used to deliver the therapeutics agents because of their ability to
provide controlled, and sustained delivery of drugs, while offering temporary surface
functionality. When the degradable top film had completely eroded, the surface would then be
left with the permanent microbicidal film for long-term prevention of fouling by biomolecules
and microorganisms (e.g., proteins and bacteria). The influence of the choice of polyions,
assembly and post-assembly conditions to the morphology of layer-by-layer assembled films was
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investigated and key challenges were overcome to build the necessary groundwork in designing
an ultrathin microbicidal / antifouling coating for various medical implant surface coating
applications, as well as numerous other applications including filtration membranes, food
packaging, commonly handled objects, and many more.
The design of the ultrathin microbicidal film requires a fundamental understanding of the
mechanism of killing of the N-alkylated polycation; it kills bacteria or inactivates viruses by
rupturing the membranes of the pathogens with its cationic charges and hydrophobic alkyl
chains. 74,113 With this knowledge in mind, we hypothesize that in order for the microbicidal
polycation to retain its potency, the polymeric chains have to be incorporated into a LbL film
with loose conformations where most of the positive charges and hydrophobic alkyl chains are
free to interact with the microbes' membranes. In chapter two, a systematic study in which the
choice of polyanion, hydrophobicity of the N-alkylated polycation, assembly and post-assembly
conditions were investigated to understand the parameters that influence the microbicidal activity
of the LbL films. This led to the confirmation of our hypothesis; films that were built with a
weakly charged polyanion (i.e., poly (acrylic acid) at an assembly pH below its pKa) showed the
maximum microbicidal activity, while films that were built with a highly charged strong
polyanion showed no activity. Having a weakly charged polyanion layer yields the subsequent
microbicidal polycation layer with loopier brush-like conformations where most of its cationic
charges and alkyl chains available to interact with microbes' membranes. As the pH of the
polyanion used during assembly increased (i.e., degree of ionization was increased), the
microbicidal activity of the films decreased; films built at this assembly condition were highly
ionically crosslinked leaving very few positive charges available to interact with microbes'
membranes. Importantly, the films showed broad-spectrum waterborne and airborne
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microbicidal activity against Gram positive and Gram negative bacteria, as well as the influenza
A/WSN (HINI) virus. The microbicidal film developed herein was used as foundation for work
in subsequent chapters.
There has been great interest in developing drug - device combinations for medical
applications; one of the biggest unmet needs in this field is the design of a surface coating
technology that is versatile enough to be broadly applicable to various medical implications. In
chapter three, we designed a multifunctional thin film construct made by combining the
microbicidal base film with a hydrolytically degradable top film that offers controlled and
localized delivery of therapeutics. We demonstrated the adaptability of the film construct with
two degradable film architectures, where each degradable film was built on top of a permanent
microbicidal base film: 1) fast (i.e., hours) release of an antibiotic to eradicate infection at the
implant site, or 2) sustained (i.e., days) release of an anti-inflammatory drug to cope with
inflammation at the implant site due to tissue injury. Both drugs remained efficacious upon
release. The microbicidal base film retained its functionality after the degradable films had
completely eroded. More importantly, the base film was shown to prevent colonization by
bacteria from turbid media for at least two weeks, while remaining biocompatible with a couple
of mammalian cell lines. In addition, the microbicidal film was also shown to resist adsorption
of at least certain types of protein from blood plasma, opening up many more potential
applications for the permanent microbicidal film. This platform technology with multiple
functionalities within a single film construct could potentially fill some of the unmet needs in
designing bioactive coatings for medical applications.
While investigating the microbicidal film potential when in contact with biologically
relevant fluids, for example blood plasma, we discovered that the film also resisted the
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adsorption of some proteins. Biofouling by biomolecules and organisms is a major problem in
various industries, including food packaging, filtration membranes, marine equipments and so
on. This phenomenon usually results in reduction in sensitivity and efficacy of the object.
Protein adsorption on surfaces is a complex and not well understood problem. Adsorptions by
electrostatic and/or hydrophobic interactions are the main mechanisms in play; of course, other
non-specific interactions like hydrogen bonding and dipole interactions also play a role. The few
materials that effectively reduce protein adsorption (e.g., poly (ethylene glycol),
zwitterionic/mixed-charge materials, and various hydrophilic biomacromolecules) do so by steric
repulsive forces or introduction of a dense hydration layer; 139,142,144 surfaces with heterogeneities
(hydrophobic/hydrophilic regions) on the nanometer length scale have also been shown to resist
protein adsorption. 11, 132 With this knowledge, we hypothesized that the surface of our film
could present either mixed-charge or molecular-scale heterogeneities that resist protein
adsorption because the N-alkylated polycation was very hydrophobic, and the polyanion (i.e.,
PAA) was very hydrophilic opening up the possibility for nanoscale segregation to happen. In
order to test the hypothesis, in chapter four the dependence of the anti-fouling activity of the film
was investigated extensively by varying the nature of the polycation and polyanion, assembly
conditions of the films, and number of layers in the films. We saw that the film adsorbed
approximately 20 times less protein relative to an uncoated control. Changing the level of
hydrophobicity of the polycation was demonstrated to alter the surface compositions and anti-
fouling property of the films. Protein resistance was most marked for films with the polyanion
as the topmost layer, and these films showed near neutral surface charge; films with the
polycation as the topmost layer, showed highly positive surface charge. A large contact angle
hysteresis on the surface of the film was also measured, indicating a heterogeneous surface
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topology. In order to simulate interaction of a protein with the film surface, adhesion studies
with modified (COOH - or NH 2 - functionalized) AFM tips were performed; both sets of studies
showed significantly lower adhesion force on the polyanion-topped film as compared to the
polycation-topped film, in agreement with other experimental results. Also, long range repulsion
of the modified tip from the surface was not observed, indicating that there was no induced layer
of hydration present on the surface of our film, suggesting that the mixed-charge hydration
repulsion hypothesis does not apply to our system. SEM images showed nanoscale domains
within the range where they would be able to reduce stable protein adsorption on the polyanion-
topped film as well. This evidence along with the contact angle hysteresis data showing a
heterogeneous surface, we think that the anti-fouling property of our film is mainly due to the
existence of molecular-scale hydrophobic/hydrophilic domains on the surface.
In chapter five, we would like to further understand the mechanism by which the LbL
coatings inactivate the microbes (bacteria and virus). Various characterization methods were
used, including visualization of microbes with scanning electron microscopy (SEM), and surface
chemistry characterization with grazing angle FT-IR). More importantly, we would like to
confirm that the formation of LbL film did not alter the mechanism in which the microbicidal
polycation itself inactivates microbes. We observed that microbes' membranes were
significantly damaged upon exposure to the film-coated surfaces. Also, from grazing angle FT-
IR experiments, the peaks in the spectra showed up at the same wave numbers for both types of
films (LbL and "painted"), suggesting that the conformation of the polymeric chains was only
partially extended and was not significantly perturbed by the formation of LbL film.
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6.2 Future Work
Several recommendations can be made to further demonstrate the practicality of the
multifunctional coatings developed in this thesis work. The in-vivo efficacy of the permanent
microbicidal / antifouling films should be tested in an animal model designed to study the long-
term functionality of these films. More specifically, the potential of the microbicidal film to
prevent long-term biofilm formation should be evaluated systematically in an animal model if
the technology is to be used as a surface coating for various medical implants applications in
future. The dual functional film construct (microbicidal and drug releasing) developed here will
also need to be evaluated in-vivo, for a specific application. For example, the antibiotic
releasing film with the underlying contact killing film will be well suited for localized prevention
of infection at an implant site; so, an infection animal model will be ideal for evaluating its
efficacy in-vivo.
Considering that the microbicidal film also has antifouling functionality, this film can
potentially be used as surface coatings for diagnostics and filtration membranes applications
where low binding of proteins are important to prevent the loss of functionality of the devices.
From this aspect, future work can be focused on coating the films directly on these surfaces and
test the efficacy of the films in those contexts. Depending on the application at hand, the
duration at which the film needs to be active varies; for example, for one-time use filtration
membrane, the antifouling film will need to be functional only, during which the membrane is
being used. Of course, if the film is used as surface coating for long-term application, then the
functionality of the film with repeated exposures will need to be evaluated.
Especially for use in medical implant applications, the extended lifetime of the films in
biologically relevant environment will have to be investigated. Most of the time, an implant will
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stay in a person's body for more than 10 years; although the microbicidal / antifouling
functionality of the film may not be needed for the entire lifetime of the implant, but it is critical
that the film remains active during the period it is needed, and after that, long-term cytotoxicity
of the film within a person's body will need to be evaluated.
The mechanical robustness and chemical stability of the films in various environments
will need to be considered as well, especially if we are to use the coatings on commonly handled
objects. The life span of the film will need to be investigated, to find the best application for the
film technology; I imagine that the microbicidal film has great potential as a top coating on an
adhesive protective coating, for example on touch screen protector that can be changed easily
when it's worn out. As portable personal devices like smartphones, tablets, and many other
entertainment consoles become popular, the market for hygienic touch surfaces increases
dramatically. Also, the microbicidal film can be very well suited as a top coating on one-time
use adhesive bandage, which usually has a shorter lifespan, and not expose to harsh mechanical
or chemical environments.
One of the challenges of coating porous substrates (e.g., textiles, membranes, bandages,
etc) is to form uniform and conformal coating on the large surface area within the fibers or pores
of these substrates. With the conventional dip LbL method, when the porous substrates are
immersed in the polymer solution, the subsequent rinse steps cannot effectively remove the
nonspecifically bound materials; this results in buildup of non uniform films or worst case no
film buildup. In recent years, other methods of LbL assembly has been developed, including
spray LbL and spin LbL. 48,49,69 Similar to dip LbL method, spray LbL assembles films via
electrostatic interactions between the oppositely charged species, but the process times can be
reduced more than 25-fold by convectively transporting the materials to the surface, versus
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diffusion-based transport of material in dip assembly. 4 Most importantly, spray LbL has been
shown to form highly conformal coatings on individual fibers or pores of porous substrates (e.g.,
textiles, electrospun mats, etc.); this is accomplished by drawing a pressure gradient across the
porous substrates during the spray LbL process. The microbicidal films investigated in this
thesis work were all built with the dip LbL method; future work looking into other method of
LbL assembly, especially spray LbL to deposit the microbicidal film on porous substrates will
open up more potential uses of this film technology. A foreseeable challenge to overcome with
using spray LbL to assemble the microbicidal film is the solvent disparity between the polycation
and polyanion; as mentioned before, the polycation only dissolves in organic solvent, and the
polyanion is in aqueous solution. Because the kinetics of film deposition in spray LbL are
different from dip LbL, the buildup of film in this solvent disparity situation could be very
unpredictable. A systematic study looking into the various parameters ( e.g., spray time, speed,
distance of sprayer from substrate, etc.) involved in spray LbL will be necessary to ensure
successful buildup of functionally active films.
The potential for infection to occur exists virtually everywhere, in surgical procedures,
everyday encounters, and many more; therefore, the research presented here has many possible
applications in various different industries. Although the research presented here focused on
designing films with permanent contact killing microbicidal activity, the knowledge gained and
groundwork laid here can be applied to the design of other bioactive film coating. The insights
into how microbes are killed by these films could open up new ways of designing films that kill
them on contact. The same applies for the information gained in designing films with antifouling
activity. The work presented herein will expand the scope of use of multilayer films in various
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applications particularly in preventing the spread of infections and fouling of surfaces by
proteins, both of which cause billion of dollars in cost annually.
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